Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Inflamm Bowel Dis

Retrieve available abstracts of 617 articles:
HTML format
Text format



Single Articles


    December 2017
  1. HYAMS JS, Chan D, Adedokun OJ, Padgett L, et al
    Subcutaneous Golimumab in Pediatric Ulcerative Colitis: Pharmacokinetics and Clinical Benefit.
    Inflamm Bowel Dis. 2017;23:2227-2237.
    PubMed     Text format     Abstract available


  2. BARNES EL, Kochar B, Long MD, Martin CF, et al
    Minority Pediatric Patients with Inflammatory Bowel Disease Demonstrate an Increased Length of Stay.
    Inflamm Bowel Dis. 2017;23:2189-2196.
    PubMed     Text format     Abstract available


  3. YE Z, Zhou Y, Huang Y, Wang Y, et al
    Phenotype and Management of Infantile-onset Inflammatory Bowel Disease: Experience from a Tertiary Care Center in China.
    Inflamm Bowel Dis. 2017;23:2154-2164.
    PubMed     Text format     Abstract available


  4. EL-MATARY W, Dykes DMH, Bauman L, Elkadri A, et al
    Rapid Infliximab Infusion in Children with Inflammatory Bowel Disease: A Multicenter North American Experience.
    Inflamm Bowel Dis. 2017;23:2104-2108.
    PubMed     Text format     Abstract available


  5. SELINGER CP, Lenti MV, Clark T, Rafferty H, et al
    Infliximab Therapeutic Drug Monitoring Changes Clinical Decisions in a Virtual Biologics Clinic for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:2083-2088.
    PubMed     Text format     Abstract available


  6. ARSENEAU KKO, Cominelli F
    Improving the Reproducibility and Quality of Reporting for Animal Studies in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:2069-2071.
    PubMed     Text format    


    November 2017
  7. SHIBATA W, Sohara M, Wu R, Kobayashi K, et al
    Incidence and Outcomes of Central Venous Catheter-related Blood Stream Infection in Patients with Inflammatory Bowel Disease in Routine Clinical Practice Setting.
    Inflamm Bowel Dis. 2017;23:2042-2047.
    PubMed     Text format     Abstract available


  8. HOPKINS CWP
    Inflammatory Bowel Disease, the Hospital Anxiety and Depression Scale and Criterion Contamination.
    Inflamm Bowel Dis. 2017;23:E54.
    PubMed     Text format    


    October 2017
  9. ANDERSON A, Click B, Ramos-Rivers C, Cheng D, et al
    Lasting Impact of Clostridium difficile Infection in Inflammatory Bowel Disease: A Propensity Score Matched Analysis.
    Inflamm Bowel Dis. 2017 Oct 27. doi: 10.1097/MIB.0000000000001251.
    PubMed     Text format     Abstract available


  10. GAWRONSKA A, Banasiuk M, Lachowicz D, Pituch H, et al
    Metronidazole or Rifaximin for Treatment of Clostridium difficile in Pediatric Patients with Inflammatory Bowel Disease: A Randomized Clinical Trial.
    Inflamm Bowel Dis. 2017 Oct 27. doi: 10.1097/MIB.0000000000001249.
    PubMed     Text format     Abstract available


  11. ZHANG W, Teng G, Wu T, Tian Y, et al
    Expression and Clinical Significance of Elafin in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Oct 27. doi: 10.1097/MIB.0000000000001252.
    PubMed     Text format     Abstract available


  12. SIGURDSSON GV, Schmidt S, Mellstrom D, Ohlsson C, et al
    Bone Mass Development from Childhood into Young Adulthood in Patients with Childhood-onset Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Oct 20. doi: 10.1097/MIB.0000000000001277.
    PubMed     Text format     Abstract available


  13. CONRAD MA, Dawany N, Sullivan KE, Devoto M, et al
    Novel ZBTB24 Mutation Associated with Immunodeficiency, Centromere Instability, and Facial Anomalies Type-2 Syndrome Identified in a Patient with Very Early Onset Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Oct 11. doi: 10.1097/MIB.0000000000001280.
    PubMed     Text format     Abstract available


  14. PONTE A, Pinho R, Fernandes S, Rodrigues A, et al
    Impact of Histological and Endoscopic Remissions on Clinical Recurrence and Recurrence-free Time in Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Oct 6. doi: 10.1097/MIB.0000000000001275.
    PubMed     Text format     Abstract available


  15. ANANTHAKRISHNAN AN, Khalili H, Song M, Higuchi LM, et al
    Genetic Polymorphisms in Fatty Acid Metabolism Modify the Association Between Dietary n3: n6 Intake and Risk of Ulcerative Colitis: A Prospective Cohort Study.
    Inflamm Bowel Dis. 2017 Oct 6. doi: 10.1097/MIB.0000000000001236.
    PubMed     Text format     Abstract available


  16. SO J, Tang W, Leung WK, Li M, et al
    Cancer Risk in 2621 Chinese Patients with Inflammatory Bowel Disease: A Population-based Cohort Study.
    Inflamm Bowel Dis. 2017 Oct 6. doi: 10.1097/MIB.0000000000001240.
    PubMed     Text format     Abstract available


  17. RIVIERE P, Poullenot F, Zerbib F, Laharie D, et al
    Quality of Sex Life in Patients with Inflammatory Bowel Disease: The Gastroenterologists' Perspective.
    Inflamm Bowel Dis. 2017;23:E51-E52.
    PubMed     Text format    


  18. CALDERA F, Wasan SK, Farraye FA, Hayney MS, et al
    Caution When Assessing Immunity to Varicella Through Antibody Testing in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:E50-E51.
    PubMed     Text format    


  19. GALLINGER ZR, Rumman A, Pivovarov K, Fortinsky KJ, et al
    Frequency and Variables Associated with Fasting Orders in Inpatients with Ulcerative Colitis: The Audit of Diet Orders-Ulcerative Colitis (ADORE-UC) Study.
    Inflamm Bowel Dis. 2017;23:1790-1795.
    PubMed     Text format     Abstract available


  20. NARULA N, Kassam Z, Yuan Y, Colombel JF, et al
    Systematic Review and Meta-analysis: Fecal Microbiota Transplantation for Treatment of Active Ulcerative Colitis.
    Inflamm Bowel Dis. 2017;23:1702-1709.
    PubMed     Text format     Abstract available


  21. CROSS RK
    Safety Considerations with the Use of Corticosteroids and Biologic Therapies in Mild-to-Moderate Ulcerative Colitis.
    Inflamm Bowel Dis. 2017;23:1689-1701.
    PubMed     Text format     Abstract available


  22. LIU X, Yu R, Zhu L, Hou X, et al
    Bidirectional Regulation of Circadian Disturbance and Inflammation in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:1741-1751.
    PubMed     Text format     Abstract available


    September 2017
  23. KRAWIEC P, Mroczkowska-Juchkiewicz A, Pac-Kozuchowska E
    Serum Hepcidin in Children with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Sep 22. doi: 10.1097/MIB.0000000000001245.
    PubMed     Text format     Abstract available


  24. ROBLIN X, Boschetti G, Duru G, Williet N, et al
    Distinct Thresholds of Infliximab Trough Level Are Associated with Different Therapeutic Outcomes in Patients with Inflammatory Bowel Disease: A Prospective Observational Study.
    Inflamm Bowel Dis. 2017 Sep 22. doi: 10.1097/MIB.0000000000001223.
    PubMed     Text format     Abstract available


  25. PETERSEN BS, August D, Abt R, Alddafari M, et al
    Targeted Gene Panel Sequencing for Early-onset Inflammatory Bowel Disease and Chronic Diarrhea.
    Inflamm Bowel Dis. 2017 Sep 19. doi: 10.1097/MIB.0000000000001235.
    PubMed     Text format     Abstract available


  26. NGUYEN VQ, Jiang D, Hoffman SN, Guntaka S, et al
    Impact of Diagnostic Delay and Associated Factors on Clinical Outcomes in a U.S. Inflammatory Bowel Disease Cohort.
    Inflamm Bowel Dis. 2017 Sep 6. doi: 10.1097/MIB.0000000000001257.
    PubMed     Text format     Abstract available


  27. VANCAMELBEKE M, Vanuytsel T, Farre R, Verstockt S, et al
    Genetic and Transcriptomic Bases of Intestinal Epithelial Barrier Dysfunction in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Sep 6. doi: 10.1097/MIB.0000000000001246.
    PubMed     Text format     Abstract available


  28. PARK KT, Heida A, van Rheenen PF
    Standardizing Fecal Calprotectin Monitoring in Asymptomatic Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:E47.
    PubMed     Text format    


  29. DAI C, Cao Q, Jiang M
    Clinical Utility of Fecal Calprotectin Monitoring in Asymptomatic Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:E46-E47.
    PubMed     Text format    


  30. PAPAMICHAEL K, Casteele NV, Ferrante M, Gils A, et al
    Therapeutic Drug Monitoring During Induction of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease: Defining a Therapeutic Drug Window.
    Inflamm Bowel Dis. 2017;23:1510-1515.
    PubMed     Text format     Abstract available


  31. TANG MS, Bowcutt R, Leung JM, Wolff MJ, et al
    Integrated Analysis of Biopsies from Inflammatory Bowel Disease Patients Identifies SAA1 as a Link Between Mucosal Microbes with TH17 and TH22 Cells.
    Inflamm Bowel Dis. 2017;23:1544-1554.
    PubMed     Text format     Abstract available


    August 2017
  32. ALLEGRETTI J, Eysenbach LM, El-Nachef N, Fischer M, et al
    The Current Landscape and Lessons from Fecal Microbiota Transplantation for Inflammatory Bowel Disease: Past, Present, and Future.
    Inflamm Bowel Dis. 2017 Aug 29. doi: 10.1097/MIB.0000000000001247.
    PubMed     Text format     Abstract available


  33. LIGHTNER AL, McKenna NP, Moncrief S, Pemberton JH, et al
    Surgical Outcomes in Vedolizumab-Treated Patients with Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Aug 29. doi: 10.1097/MIB.0000000000001248.
    PubMed     Text format     Abstract available


  34. KONIJETI GG, Kim N, Lewis JD, Groven S, et al
    Efficacy of the Autoimmune Protocol Diet for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Aug 29. doi: 10.1097/MIB.0000000000001221.
    PubMed     Text format     Abstract available


  35. KAMMERLANDER H, Nielsen J, Knudsen T, Kjeldsen J, et al
    Anti-TNF-alpha Use During the Third Trimester of Pregnancy in Women with Moderate-severe Inflammatory Bowel Disease and the Risk of Preterm Birth and Low Birth Weight.
    Inflamm Bowel Dis. 2017 Aug 29. doi: 10.1097/MIB.0000000000001234.
    PubMed     Text format     Abstract available


  36. MUDIREDDY P, Scott F, Feathers A, Lichtenstein GR, et al
    Inflammatory Bowel Disease: Predictors and Causes of Early and Late Hospital Readmissions.
    Inflamm Bowel Dis. 2017 Aug 29. doi: 10.1097/MIB.0000000000001242.
    PubMed     Text format     Abstract available


  37. CALDERA F, Wasan SK, Farraye FA, Hayney MS, et al
    Caution When Assessing Immunity to Varicella Through Antibody Testing in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Aug 23. doi: 10.1097/MIB.0000000000001239.
    PubMed     Text format    


  38. NARULA N, Kassam Z, Yuan Y, Colombel JF, et al
    Systematic Review and Meta-analysis: Fecal Microbiota Transplantation for Treatment of Active Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Aug 23. doi: 10.1097/MIB.0000000000001228.
    PubMed     Text format     Abstract available


  39. HYAMS JS, Kugathasan S, Dubinsky MC
    Combination Therapy in Pediatric Inflammatory Bowel Disease: Yes, No, Maybe.
    Inflamm Bowel Dis. 2017 Aug 22. doi: 10.1097/MIB.0000000000001206.
    PubMed     Text format    


  40. CHRISTIAN KE, Jambaulikar GD, Hagan MN, Syed AM, et al
    Predictors of Early Readmission in Hospitalized Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Aug 22. doi: 10.1097/MIB.0000000000001213.
    PubMed     Text format     Abstract available


  41. GOLD SL, Cohen-Mekelburg S, Schneider Y, Shen N, et al
    Premedication Use in Preventing Acute Infliximab Infusion Reactions in Patients with Inflammatory Bowel Disease: A Single Center Cohort Study.
    Inflamm Bowel Dis. 2017 Aug 22. doi: 10.1097/MIB.0000000000001189.
    PubMed     Text format     Abstract available


  42. BHANDARI S, Mohammed Abdul MK, Dhakal B, Kreuziger LB, et al
    Increased Rate of Venous Thromboembolism in Hospitalized Inflammatory Bowel Disease Patients with Clostridium Difficile Infection.
    Inflamm Bowel Dis. 2017 Aug 22. doi: 10.1097/MIB.0000000000001218.
    PubMed     Text format     Abstract available


  43. CHENG J, Hamilton Z, Smyth M, Barker C, et al
    Concomitant Therapy with Immunomodulator Enhances Infliximab Durability in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Aug 22. doi: 10.1097/MIB.0000000000001212.
    PubMed     Text format     Abstract available


  44. LU Y, Zamora-Ros R, Chan S, Cross AJ, et al
    Dietary Polyphenols in the Aetiology of Crohn's Disease and Ulcerative Colitis-A Multicenter European Prospective Cohort Study (EPIC).
    Inflamm Bowel Dis. 2017 Aug 22. doi: 10.1097/MIB.0000000000001108.
    PubMed     Text format     Abstract available


  45. LI SX, Thompson KD, Peterson T, Huneven S, et al
    Delivering High Value Inflammatory Bowel Disease Care Through Telemedicine Visits.
    Inflamm Bowel Dis. 2017 Aug 16. doi: 10.1097/MIB.0000000000001210.
    PubMed     Text format     Abstract available


  46. BRAMUZZO M, Stocco G, Montico M, Arrigo S, et al
    Risk Factors and Outcomes of Thalidomide-induced Peripheral Neuropathy in a Pediatric Inflammatory Bowel Disease Cohort.
    Inflamm Bowel Dis. 2017 Aug 16. doi: 10.1097/MIB.0000000000001195.
    PubMed     Text format     Abstract available


  47. KLAG T, Mazurak N, Fantasia L, Schwille-Kiuntke J, et al
    High Demand for Psychotherapy in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Aug 16. doi: 10.1097/MIB.0000000000001216.
    PubMed     Text format     Abstract available


  48. PARK KT, Heida A, van Rheenen PF
    Standardizing Fecal Calprotectin Monitoring in Asymptomatic Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Aug 14. doi: 10.1097/MIB.0000000000001229.
    PubMed     Text format    


  49. DAI C, Cao Q, Jiang M
    Clinical Utility of Fecal Calprotectin Monitoring in Asymptomatic Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Aug 14. doi: 10.1097/MIB.0000000000001225.
    PubMed     Text format    


  50. PAPAMICHAEL K, Casteele NV, Ferrante M, Gils A, et al
    Therapeutic Drug Monitoring During Induction of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease: Defining a Therapeutic Drug Window.
    Inflamm Bowel Dis. 2017 Aug 14. doi: 10.1097/MIB.0000000000001231.
    PubMed     Text format     Abstract available


  51. ISAKOV O, Dotan I, Ben-Shachar S
    Machine Learning-Based Gene Prioritization Identifies Novel Candidate Risk Genes for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Aug 8. doi: 10.1097/MIB.0000000000001222.
    PubMed     Text format     Abstract available


  52. MARIN-JIMENEZ I, Gobbo Montoya M, Panadero A, Canas M, et al
    Management of the Psychological Impact of Inflammatory Bowel Disease: Perspective of Doctors and Patients-The ENMENTE Project.
    Inflamm Bowel Dis. 2017 Aug 3. doi: 10.1097/MIB.0000000000001205.
    PubMed     Text format     Abstract available


  53. PEPE J, Zawadynski S, Herrmann FR, Juillerat P, et al
    Structural Basis of Bone Fragility in Young Subjects with Inflammatory Bowel Disease: A High-resolution pQCT Study of the SWISS IBD Cohort (SIBDC).
    Inflamm Bowel Dis. 2017;23:1410-1417.
    PubMed     Text format     Abstract available


  54. JOLVING LR, Nielsen J, Beck-Nielsen SS, Nielsen RG, et al
    The Association Between Maternal Chronic Inflammatory Bowel Disease and Long-term Health Outcomes in Children-A Nationwide Cohort Study.
    Inflamm Bowel Dis. 2017;23:1440-1446.
    PubMed     Text format     Abstract available


  55. SUN C, Zhao Y, Gao X, Yuan Y, et al
    Cideb Deficiency Aggravates Dextran Sulfate Sodium-induced Ulcerative Colitis in Mice by Exacerbating the Oxidative Burden in Colonic Mucosa.
    Inflamm Bowel Dis. 2017;23:1338-1347.
    PubMed     Text format     Abstract available


  56. AL-DARMAKI A, Hubbard J, Seow CH, Leung Y, et al
    Clinical Predictors of the Risk of Early Colectomy in Ulcerative Colitis: A Population-based Study.
    Inflamm Bowel Dis. 2017;23:1272-1277.
    PubMed     Text format     Abstract available


  57. TIAO DK, Chan W, Jeganathan J, Chan JT, et al
    Inflammatory Bowel Disease Pharmacist Adherence Counseling Improves Medication Adherence in Crohn's Disease and Ulcerative Colitis.
    Inflamm Bowel Dis. 2017;23:1257-1261.
    PubMed     Text format     Abstract available


    July 2017
  58. BAKER DM, Marshall JH, Lee MJ, Jones GL, et al
    A Systematic Review of Internet Decision-Making Resources for Patients Considering Surgery for Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Jul 12. doi: 10.1097/MIB.0000000000001198.
    PubMed     Text format     Abstract available


  59. COHN HM, Dave M, Loftus EV Jr
    Understanding the Cautions and Contraindications of Immunomodulator and Biologic Therapies for Use in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Jul 12. doi: 10.1097/MIB.0000000000001199.
    PubMed     Text format     Abstract available


  60. AGUAS PERIS M, Boso V, Navarro B, Marques-Minana MR, et al
    Serum Adalimumab Levels Predict Successful Remission and Safe Deintensification in Inflammatory Bowel Disease Patients in Clinical Practice.
    Inflamm Bowel Dis. 2017 Jul 12. doi: 10.1097/MIB.0000000000001182.
    PubMed     Text format     Abstract available


  61. MARTIN T, Smukalla SM, Kane S, Hudesman DP, et al
    Receptive Anal Intercourse in Patients with Inflammatory Bowel Disease: A Clinical Review.
    Inflamm Bowel Dis. 2017 Jul 12. doi: 10.1097/MIB.0000000000001186.
    PubMed     Text format     Abstract available


  62. VOSKENS CJ, Fischer A, Roessner S, Lorenz C, et al
    Characterization and Expansion of Autologous GMP-ready Regulatory T Cells for TREG-based Cell Therapy in Patients with Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Jul 12. doi: 10.1097/MIB.0000000000001192.
    PubMed     Text format     Abstract available


  63. SYED S, Michalski ES, Tangpricha V, Chesdachai S, et al
    Vitamin D Status Is Associated with Hepcidin and Hemoglobin Concentrations in Children with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Jul 11. doi: 10.1097/MIB.0000000000001178.
    PubMed     Text format     Abstract available


  64. SEVERS M, Mangen MJ, Fidder HH, van der Valk ME, et al
    Clinical Predictors of Future Nonadherence in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Jul 11. doi: 10.1097/MIB.0000000000001201.
    PubMed     Text format     Abstract available


  65. MATSUNO H, Kayama H, Nishimura J, Sekido Y, et al
    CD103+ Dendritic Cell Function Is Altered in the Colons of Patients with Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Jul 11. doi: 10.1097/MIB.0000000000001204.
    PubMed     Text format     Abstract available


  66. STARK CM, Gorman GH, Nylund CM
    Association of Inflammatory Bowel Disease and Urolithiasis in Hospitalized Pediatric Patients.
    Inflamm Bowel Dis. 2017 Jul 10. doi: 10.1097/MIB.0000000000001188.
    PubMed     Text format     Abstract available


  67. ROBER N, Noss L, Goihl A, Reinhold D, et al
    Autoantibodies Against Glycoprotein 2 Isoforms in Pediatric Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Jul 6. doi: 10.1097/MIB.0000000000001159.
    PubMed     Text format     Abstract available


  68. JANMOHAMED N, Steinhart AH
    Measuring Severity of Anxiety and Depression in Patients with Inflammatory Bowel Disease: Low Concordance Between Patients and Male Gastroenterologists.
    Inflamm Bowel Dis. 2017;23:1168-1173.
    PubMed     Text format     Abstract available


  69. KHALILI H, de Silva PS, Ananthakrishnan AN, Lochhead P, et al
    Dietary Iron and Heme Iron Consumption, Genetic Susceptibility, and Risk of Crohn's Disease and Ulcerative Colitis.
    Inflamm Bowel Dis. 2017;23:1088-1095.
    PubMed     Text format     Abstract available


    June 2017
  70. TAXONERA C, Rodriguez C, Bertoletti F, Menchen L, et al
    Clinical Outcomes of Golimumab as First, Second or Third Anti-TNF Agent in Patients with Moderate-to-Severe Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Jun 30. doi: 10.1097/MIB.0000000000001144.
    PubMed     Text format     Abstract available


  71. MA C, Lumb R, Walker EV, Foshaug RR, et al
    Noninvasive Fecal Immunochemical Testing and Fecal Calprotectin Predict Mucosal Healing in Inflammatory Bowel Disease: A Prospective Cohort Study.
    Inflamm Bowel Dis. 2017 Jun 20. doi: 10.1097/MIB.0000000000001173.
    PubMed     Text format     Abstract available


  72. CARLSEN K, Houen G, Jakobsen C, Kallemose T, et al
    Individualized Infliximab Treatment Guided by Patient-managed eHealth in Children and Adolescents with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Jun 14. doi: 10.1097/MIB.0000000000001170.
    PubMed     Text format     Abstract available


  73. MEIJER B, Seinen ML, van Egmond R, Bouma G, et al
    Optimizing Thiopurine Therapy in Inflammatory Bowel Disease Among 2 Real-life Intercept Cohorts: Effect of Allopurinol Comedication?
    Inflamm Bowel Dis. 2017 Jun 14. doi: 10.1097/MIB.0000000000001168.
    PubMed     Text format     Abstract available


  74. EPPINGA H, Poortinga S, Thio HB, Nijsten TEC, et al
    Prevalence and Phenotype of Concurrent Psoriasis and Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Jun 14. doi: 10.1097/MIB.0000000000001169.
    PubMed     Text format     Abstract available


  75. PEDERSEN M, Cromwell J, Nau P
    Sarcopenia is a Predictor of Surgical Morbidity in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Jun 9. doi: 10.1097/MIB.0000000000001166.
    PubMed     Text format     Abstract available


  76. PEKOW J, Hutchison AL, Meckel K, Harrington K, et al
    miR-4728-3p Functions as a Tumor Suppressor in Ulcerative Colitis-associated Colorectal Neoplasia Through Regulation of Focal Adhesion Signaling.
    Inflamm Bowel Dis. 2017 Jun 7. doi: 10.1097/MIB.0000000000001104.
    PubMed     Text format     Abstract available


  77. KOPYLOV U, Papamichael K, Katsanos K, Waterman M, et al
    Impact of Infliximab and Cyclosporine on the Risk of Colectomy in Hospitalized Patients with Ulcerative Colitis Complicated by Cytomegalovirus-A Multicenter Retrospective Study.
    Inflamm Bowel Dis. 2017 Jun 5. doi: 10.1097/MIB.0000000000001160.
    PubMed     Text format     Abstract available


  78. PATEL A, Panchal H, Dubinsky MC
    Fecal Calprotectin Levels Predict Histological Healing in Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Jun 5. doi: 10.1097/MIB.0000000000001157.
    PubMed     Text format     Abstract available


  79. AXELRAD JE, Joelson A, Nobel YR, Lawlor G, et al
    Enteric Infection in Relapse of Inflammatory Bowel Disease: The Utility of Stool Microbial PCR Testing.
    Inflamm Bowel Dis. 2017;23:1034-1039.
    PubMed     Text format     Abstract available


  80. GLASSNER K, Malaty HM, Abraham BP
    Epidemiology and Risk Factors of Nonalcoholic Fatty Liver Disease Among Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:998-1003.
    PubMed     Text format     Abstract available


  81. HEIDA A, Park KT, van Rheenen PF
    Clinical Utility of Fecal Calprotectin Monitoring in Asymptomatic Patients with Inflammatory Bowel Disease: A Systematic Review and Practical Guide.
    Inflamm Bowel Dis. 2017;23:894-902.
    PubMed     Text format     Abstract available


  82. NGUYEN GC, Boland K, Afif W, Bressler B, et al
    Modified Delphi Process for the Development of Choosing Wisely for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:858-865.
    PubMed     Text format     Abstract available


  83. YADAV A, Foromera J, Feuerstein I, Falchuk KR, et al
    Variations in Health Insurance Policies Regarding Biologic Therapy Use in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:853-857.
    PubMed     Text format     Abstract available


  84. BERRY AC, Dholaria K, Czul-Gurdian F, Forster E, et al
    Relationship Between Patient Knowledge and Medication Adherence in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:E39-E40.
    PubMed     Text format    


  85. HOPKINS CWP, Butt HS, Moulton CD
    Beyond Efficacy: The Acceptability of Antidepressant Treatment to Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:E38.
    PubMed     Text format    


    May 2017
  86. DAN A, Boutros M, Nedjar H, Kopylov U, et al
    Cost of Ulcerative Colitis in Quebec, Canada: A Retrospective Cohort Study.
    Inflamm Bowel Dis. 2017 May 29. doi: 10.1097/MIB.0000000000001147.
    PubMed     Text format     Abstract available


  87. BUISSON A, Gonzalez F, Poullenot F, Nancey S, et al
    Comparative Acceptability and Perceived Clinical Utility of Monitoring Tools: A Nationwide Survey of Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 May 24. doi: 10.1097/MIB.0000000000001140.
    PubMed     Text format     Abstract available


  88. LOPEZ RN, Evans HM, Appleton L, Bishop J, et al
    Point Prevalence of Pediatric Inflammatory Bowel Disease in New Zealand in 2015: Initial Results from the PINZ Study.
    Inflamm Bowel Dis. 2017 May 24. doi: 10.1097/MIB.0000000000001138.
    PubMed     Text format     Abstract available


  89. FEAGINS LA, Waljee A, Hou JK, Gu P, et al
    Incidence of and Predictors for Early Discontinuation of Biological Therapies in Veteran Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 May 24. doi: 10.1097/MIB.0000000000001145.
    PubMed     Text format     Abstract available


  90. CHAO K, Wang X, Cao Q, Qian J, et al
    Combined Detection of NUDT15 Variants Could Highly Predict Thiopurine-induced Leukopenia in Chinese Patients with Inflammatory Bowel Disease: A Multicenter Analysis.
    Inflamm Bowel Dis. 2017 May 24. doi: 10.1097/MIB.0000000000001148.
    PubMed     Text format     Abstract available


  91. BORREN NZ, Conway G, Tan W, Andrews E, et al
    Distance to Specialist Care and Disease Outcomes in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 May 16. doi: 10.1097/MIB.0000000000001133.
    PubMed     Text format     Abstract available


  92. VALER P, Algaba A, Santos D, Fuentes ME, et al
    Evaluation of the Quality of Semen and Sexual Function in Men with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 May 16. doi: 10.1097/MIB.0000000000001081.
    PubMed     Text format     Abstract available


  93. FATTAHI MR, Malek-Hosseini SA, Sivandzadeh GR, Safarpour AR, et al
    Clinical Course of Ulcerative Colitis After Liver Transplantation in Patients with Concomitant Primary Sclerosing Cholangitis and Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 May 16. doi: 10.1097/MIB.0000000000001105.
    PubMed     Text format     Abstract available


  94. NGUYEN GC, Boland K, Afif W, Bressler B, et al
    Modified Delphi Process for the Development of Choosing Wisely for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 May 15. doi: 10.1097/MIB.0000000000001152.
    PubMed     Text format     Abstract available


  95. YADAV A, Foromera J, Feuerstein I, Falchuk KR, et al
    Variations in Health Insurance Policies Regarding Biologic Therapy Use in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 May 15. doi: 10.1097/MIB.0000000000001153.
    PubMed     Text format     Abstract available


  96. JULSGAARD M, Hvas CL, Gearry RB, Vestergaard T, et al
    Fecal Calprotectin Is Not Affected by Pregnancy: Clinical Implications for the Management of Pregnant Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 May 11. doi: 10.1097/MIB.0000000000001136.
    PubMed     Text format     Abstract available


  97. RESTALL GJ, Simms AM, Walker JR, Haviva C, et al
    Coping with Inflammatory Bowel Disease: Engaging with Information to Inform Health-Related Decision Making in Daily Life.
    Inflamm Bowel Dis. 2017 May 11. doi: 10.1097/MIB.0000000000001141.
    PubMed     Text format     Abstract available


  98. KELLY OB, Donnell SO, Stempak JM, Steinhart AH, et al
    Therapeutic Drug Monitoring to Guide Infliximab Dose Adjustment is Associated with Better Endoscopic Outcomes than Clinical Decision Making Alone in Active Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 May 11. doi: 10.1097/MIB.0000000000001126.
    PubMed     Text format     Abstract available


  99. JEGANATHAN J, Lee CH, Rahme A, Tiao DK, et al
    Pediatric-to-adult Transition and Medication Adherence in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 May 11. doi: 10.1097/MIB.0000000000001114.
    PubMed     Text format     Abstract available


  100. GUNALTAY S, Repsilber D, Helenius G, Nyhlin N, et al
    Oligoclonal T-cell Receptor Repertoire in Colonic Biopsies of Patients with Microscopic Colitis and Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 May 11. doi: 10.1097/MIB.0000000000001127.
    PubMed     Text format     Abstract available


  101. YANG H, Zhou W, Lv H, Wu D, et al
    The Association Between CMV Viremia or Endoscopic Features and Histopathological Characteristics of CMV Colitis in Patients with Underlying Ulcerative Colitis.
    Inflamm Bowel Dis. 2017;23:814-821.
    PubMed     Text format     Abstract available


  102. THORLACIUS-USSING G, Schnack Nielsen B, Andersen V, Holmstrom K, et al
    Expression and Localization of miR-21 and miR-126 in Mucosal Tissue from Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:739-752.
    PubMed     Text format     Abstract available


  103. BURKE KE, Haviland MJ, Hacker MR, Shainker SA, et al
    Indications for Mode of Delivery in Pregnant Women with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:721-726.
    PubMed     Text format     Abstract available


  104. FOULON A, Dupas JL, Sabbagh C, Chevreau J, et al
    Defining the Most Appropriate Delivery Mode in Women with Inflammatory Bowel Disease: A Systematic Review.
    Inflamm Bowel Dis. 2017;23:712-720.
    PubMed     Text format     Abstract available


  105. NGUYEN GC, Murthy SK, Bressler B, Lam MCW, et al
    Quality of Care and Outcomes Among Hospitalized Inflammatory Bowel Disease Patients: A Multicenter Retrospective Study.
    Inflamm Bowel Dis. 2017;23:695-701.
    PubMed     Text format     Abstract available


    April 2017
  106. VAVRICKA SR, Gubler M, Gantenbein C, Spoerri M, et al
    Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study.
    Inflamm Bowel Dis. 2017 Apr 27. doi: 10.1097/MIB.0000000000001109.
    PubMed     Text format     Abstract available


  107. MAGNUSSON MK, Strid H, Isaksson S, Simren M, et al
    The Mucosal Antibacterial Response Profile and Fecal Microbiota Composition Are Linked to the Disease Course in Patients with Newly Diagnosed Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Apr 25. doi: 10.1097/MIB.0000000000001130.
    PubMed     Text format     Abstract available


  108. JACOB V, Crawford C, Cohen-Mekelburg S, Viladomiu M, et al
    Single Delivery of High-Diversity Fecal Microbiota Preparation by Colonoscopy Is Safe and Effective in Increasing Microbial Diversity in Active Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Apr 25. doi: 10.1097/MIB.0000000000001132.
    PubMed     Text format     Abstract available


  109. BUHL S, Steenholdt C, Rasmussen M, Borghede MK, et al
    Outcomes After Primary Infliximab Treatment Failure in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Apr 25. doi: 10.1097/MIB.0000000000001117.
    PubMed     Text format     Abstract available


  110. BARNES EL, Kochar B, Long MD, Kappelman MD, et al
    Modifiable Risk Factors for Hospital Readmission Among Patients with Inflammatory Bowel Disease in a Nationwide Database.
    Inflamm Bowel Dis. 2017 Apr 19. doi: 10.1097/MIB.0000000000001121.
    PubMed     Text format     Abstract available


  111. LIGHTNER AL, Tse CS, Quinn K, Bergquist JR, et al
    Preoperative Clostridium difficile Infection Does Not Affect Pouch Outcomes in Patients with Ulcerative Colitis Who Undergo Ileal Pouch-anal Anastomosis.
    Inflamm Bowel Dis. 2017 Apr 13. doi: 10.1097/MIB.0000000000001122.
    PubMed     Text format     Abstract available


  112. MARTINEZ B, Dailey F, Almario CV, Keller MS, et al
    Patient Understanding of the Risks and Benefits of Biologic Therapies in Inflammatory Bowel Disease: Insights from a Large-scale Analysis of Social Media Platforms.
    Inflamm Bowel Dis. 2017 Apr 13. doi: 10.1097/MIB.0000000000001110.
    PubMed     Text format     Abstract available


  113. ADAMS DW, Gurwara S, Silver HJ, Horst SN, et al
    Sarcopenia Is Common in Overweight Patients with Inflammatory Bowel Disease and May Predict Need for Surgery.
    Inflamm Bowel Dis. 2017 Apr 13. doi: 10.1097/MIB.0000000000001128.
    PubMed     Text format     Abstract available


  114. KOCHAR B, Long MD, Galanko J, Raffals LE, et al
    Inflammatory Bowel Disease is Similar in Patients with Older Onset and Younger Onset.
    Inflamm Bowel Dis. 2017 Apr 13. doi: 10.1097/MIB.0000000000001115.
    PubMed     Text format     Abstract available


  115. VARNI JW, Shulman RJ, Self MM, Saeed SA, et al
    Patient Health Communication Mediating Effects Between Gastrointestinal Symptoms and Gastrointestinal Worry in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Apr 6. doi: 10.1097/MIB.0000000000001077.
    PubMed     Text format     Abstract available


  116. BANASZKIEWICZ A, Gawronska A, Klincewicz B, Kofla-Dlubacz A, et al
    Immunogenicity of Pertussis Booster Vaccination in Children and Adolescents with Inflammatory Bowel Disease: A Controlled Study.
    Inflamm Bowel Dis. 2017 Apr 6. doi: 10.1097/MIB.0000000000001076.
    PubMed     Text format     Abstract available


  117. NAVANEETHAN U, Edminister T, Zhu X, Kommaraju K, et al
    Vedolizumab Is Safe and Effective in Elderly Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:E17.
    PubMed     Text format    


  118. KHAN A, Chandler M, Borum ML
    Patients with Inflammatory Bowel Disease May Use Electronic Communication with Their Physicians More Frequently Than Those Without Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:E16.
    PubMed     Text format    


  119. STOCCO G, Martelossi S, Arrigo S, Barabino A, et al
    Multicentric Case-Control Study on Azathioprine Dose and Pharmacokinetics in Early-onset Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:628-634.
    PubMed     Text format     Abstract available


  120. TANDON P, James P, Cordeiro E, Mallick R, et al
    Diagnostic Accuracy of Blood-Based Tests and Histopathology for Cytomegalovirus Reactivation in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Inflamm Bowel Dis. 2017;23:551-560.
    PubMed     Text format     Abstract available


  121. LAN N, Shen B
    Endoscopic Stricturotomy with Needle Knife in the Treatment of Strictures from Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:502-513.
    PubMed     Text format     Abstract available


  122. RUBIN DT, Dubinsky MC, Martino S, Hewett KA, et al
    Communication Between Physicians and Patients with Ulcerative Colitis: Reflections and Insights from a Qualitative Study of In-Office Patient-Physician Visits.
    Inflamm Bowel Dis. 2017;23:494-501.
    PubMed     Text format     Abstract available


    March 2017
  123. NARULA N, Borges L, Steinhart AH, Colombel JF, et al
    Trends in Narcotic and Corticosteroid Prescriptions in Patients with Inflammatory Bowel Disease in the United States Ambulatory Care Setting from 2003 to 2011.
    Inflamm Bowel Dis. 2017 Mar 31. doi: 10.1097/MIB.0000000000001084.
    PubMed     Text format     Abstract available


  124. SUZUKI Y, Iida M, Ito H, Nishino H, et al
    2.4 g Mesalamine (Asacol 400 mg tablet) Once Daily is as Effective as Three Times Daily in Maintenance of Remission in Ulcerative Colitis: A Randomized, Noninferiority, Multi-center Trial.
    Inflamm Bowel Dis. 2017 Mar 31. doi: 10.1097/MIB.0000000000001065.
    PubMed     Text format     Abstract available


  125. ANANTHAKRISHNAN AN, Donaldson T, Lasch K, Yajnik V, et al
    Management of Inflammatory Bowel Disease in the Elderly Patient: Challenges and Opportunities.
    Inflamm Bowel Dis. 2017 Mar 27. doi: 10.1097/MIB.0000000000001099.
    PubMed     Text format     Abstract available


  126. KAMMERLANDER H, Nielsen J, Kjeldsen J, Knudsen T, et al
    The Effect of Disease Activity on Birth Outcomes in a Nationwide Cohort of Women with Moderate to Severe Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Mar 24. doi: 10.1097/MIB.0000000000001102.
    PubMed     Text format     Abstract available


  127. HATA K, Ishii H, Anzai H, Ishihara S, et al
    Preoperative Extraintestinal Manifestations Associated with Chronic Pouchitis in Japanese Patients with Ulcerative Colitis After Ileal Pouch-anal Anastomosis: A Retrospective Study.
    Inflamm Bowel Dis. 2017 Mar 24. doi: 10.1097/MIB.0000000000001094.
    PubMed     Text format     Abstract available


  128. ZULLOW S, Fazelat A, Farraye FA
    Central Serous Chorioretinopathy in a Patient with Ulcerative Colitis with Pouchitis on Budesonide-EC.
    Inflamm Bowel Dis. 2017 Mar 21. doi: 10.1097/MIB.0000000000001091.
    PubMed     Text format    


  129. EL-MATARY W
    Indicators of Quality of Care in Inflammatory Bowel Disease: Seeking the Right Path for Patients.
    Inflamm Bowel Dis. 2017 Mar 21. doi: 10.1097/MIB.0000000000001069.
    PubMed     Text format    


  130. KHAN N, Patel D, Shah Y, Lichtenstein G, et al
    A Novel User-Friendly Model to Predict Corticosteroid Utilization in Newly Diagnosed Patients with Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Mar 21. doi: 10.1097/MIB.0000000000001080.
    PubMed     Text format     Abstract available


  131. NGUYEN GC, Murthy SK, Bressler B, Lam MC, et al
    Quality of Care and Outcomes Among Hospitalized Inflammatory Bowel Disease Patients: A Multicenter Retrospective Study.
    Inflamm Bowel Dis. 2017 Mar 21. doi: 10.1097/MIB.0000000000001068.
    PubMed     Text format     Abstract available


  132. NAVIGLIO S, Parentin F, Nider S, Rassu N, et al
    Ocular Involvement in Children with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Mar 21. doi: 10.1097/MIB.0000000000001079.
    PubMed     Text format     Abstract available


  133. ISHAK WW, Pan D, Steiner AJ, Feldman E, et al
    Patient-Reported Outcomes of Quality of Life, Functioning, and GI/Psychiatric Symptom Severity in Patients with Inflammatory Bowel Disease (IBD).
    Inflamm Bowel Dis. 2017 Mar 15. doi: 10.1097/MIB.0000000000001060.
    PubMed     Text format     Abstract available


  134. ARORA Z, Mukewar S, Lopez R, Camino D, et al
    Etiopathogenesis of Nephrolithiasis in Ulcerative Colitis Patients with the Ileal Pouch Anal Anastomosis.
    Inflamm Bowel Dis. 2017 Mar 15. doi: 10.1097/MIB.0000000000001070.
    PubMed     Text format     Abstract available


  135. LIGHTNER AL, Mathis KL, Dozois EJ, Hahnsloser D, et al
    Results at Up to 30 Years After Ileal Pouch-Anal Anastomosis for Chronic Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Mar 15. doi: 10.1097/MIB.0000000000001061.
    PubMed     Text format     Abstract available


  136. KELSEN JR, Dawany N, Conrad M, Devoto M, et al
    Commentary on Mutations in Interleukin-10 Receptor and Clinical Phenotypes in Patients with Very Early-onset Inflammatory Bowel Disease: A Chinese VEO-IBD Collaboration Group Survey.
    Inflamm Bowel Dis. 2017 Mar 6. doi: 10.1097/MIB.0000000000001028.
    PubMed     Text format    


  137. MACER BJ, Prady SL, Mikocka-Walus A
    Antidepressants in Inflammatory Bowel Disease: A Systematic Review.
    Inflamm Bowel Dis. 2017 Mar 6. doi: 10.1097/MIB.0000000000001059.
    PubMed     Text format     Abstract available


  138. HUANG Z, Peng K, Li X, Zhao R, et al
    Mutations in Interleukin-10 Receptor and Clinical Phenotypes in Patients with Very Early Onset Inflammatory Bowel Disease: A Chinese VEO-IBD Collaboration Group Survey.
    Inflamm Bowel Dis. 2017 Mar 6. doi: 10.1097/MIB.0000000000001058.
    PubMed     Text format     Abstract available


  139. SEXTON KA, Walker JR, Graff LA, Bernstein MT, et al
    Evidence of Bidirectional Associations Between Perceived Stress and Symptom Activity: A Prospective Longitudinal Investigation in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:473-483.
    PubMed     Text format     Abstract available


  140. HUANG Y, Dalal S, Antonopoulos D, Hubert N, et al
    Early Transcriptomic Changes in the Ileal Pouch Provide Insight into the Molecular Pathogenesis of Pouchitis and Ulcerative Colitis.
    Inflamm Bowel Dis. 2017;23:366-378.
    PubMed     Text format     Abstract available


  141. CARLSEN K, Jakobsen C, Houen G, Kallemose T, et al
    Self-managed eHealth Disease Monitoring in Children and Adolescents with Inflammatory Bowel Disease: A Randomized Controlled Trial.
    Inflamm Bowel Dis. 2017;23:357-365.
    PubMed     Text format     Abstract available


  142. POOJARY P, Saha A, Chauhan K, Simoes P, et al
    Predictors of Hospital Readmissions for Ulcerative Colitis in the United States: A National Database Study.
    Inflamm Bowel Dis. 2017;23:347-356.
    PubMed     Text format     Abstract available


    February 2017
  143. CARLSEN K, Jakobsen C, Houen G, Kallemose T, et al
    Self-managed eHealth Disease Monitoring in Children and Adolescents with Inflammatory Bowel Disease: A Randomized Controlled Trial.
    Inflamm Bowel Dis. 2017 Feb 13. doi: 10.1097/MIB.0000000000001026.
    PubMed     Text format     Abstract available


  144. POOJARY P, Saha A, Chauhan K, Simoes P, et al
    Predictors of Hospital Readmissions for Ulcerative Colitis in the United States: A National Database Study.
    Inflamm Bowel Dis. 2017 Feb 13. doi: 10.1097/MIB.0000000000001041.
    PubMed     Text format     Abstract available


  145. HUANG Y, Dalal S, Antonopoulos D, Hubert N, et al
    Early Transcriptomic Changes in the Ileal Pouch Provide Insight into the Molecular Pathogenesis of Pouchitis and Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Feb 13. doi: 10.1097/MIB.0000000000001027.
    PubMed     Text format     Abstract available


  146. BRANDSE JF, Mould D, Smeekes O, Ashruf Y, et al
    A Real-life Population Pharmacokinetic Study Reveals Factors Associated with Clearance and Immunogenicity of Infliximab in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Feb 10. doi: 10.1097/MIB.0000000000001043.
    PubMed     Text format     Abstract available


  147. KOPYLOV U, Ron Y, Avni-Biron I, Koslowsky B, et al
    Efficacy and Safety of Vedolizumab for Induction of Remission in Inflammatory Bowel Disease-the Israeli Real-World Experience.
    Inflamm Bowel Dis. 2017 Feb 7. doi: 10.1097/MIB.0000000000001039.
    PubMed     Text format     Abstract available


  148. RODRIGUEZ-PALACIOS A, Corridoni D, Di Stefano G, Di Martino L, et al
    O-014 Bacterial Sensor NOD2 Deletion Causes Th2-Inflammatory Bowel Disease Improvement Without Inducing Acute Metatranscriptomic Dysbiosis in Mice.
    Inflamm Bowel Dis. 2017;23 Suppl 1:S5.
    PubMed     Text format     Abstract available


  149. HABERMAN Y, Ben-Shoshan M, Di-Segni A, Dexheimer P, et al
    O-009 Long ncRNA Landscape in the Ileum of Treatment Naive Early Onset Crohn Disease.
    Inflamm Bowel Dis. 2017;23 Suppl 1:S3-S4.
    PubMed     Text format     Abstract available


  150. KIM ES, Jang BI, Kim KO, Kim EY, et al
    O-007 Impact of Education on School Nurses' Knowledge of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23 Suppl 1:S3.
    PubMed     Text format     Abstract available


  151. EL-MATARY W, Samson C, Crim A, Ali S, et al
    O-006 Rapid Infliximab Infusion in Children with Inflammatory Bowel Disease: A Multi-Center North American Experience.
    Inflamm Bowel Dis. 2017;23 Suppl 1:S2-S3.
    PubMed     Text format     Abstract available


  152. SHAKHNOVICH V, Van Haandel L, Becker M, Funk R, et al
    O-005 Combination Therapy with Methotrexate Does Not Change Infliximab Pharmacokinetics in Children with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23 Suppl 1:S2.
    PubMed     Text format     Abstract available


  153. DUPONT-LUCAS C, Grandjean-Blanchet C, Leduc B, Tripcovici M, et al
    Prevalence and Risk Factors for Symptoms of Methotrexate Intolerance in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:298-303.
    PubMed     Text format     Abstract available


  154. ALEXAKIS C, Saxena S, Chhaya V, Cecil E, et al
    Do Thiopurines Reduce the Risk of Surgery in Elderly Onset Inflammatory Bowel Disease? A 20-Year National Population-Based Cohort Study.
    Inflamm Bowel Dis. 2017 Feb 1. doi: 10.1097/MIB.0000000000001031.
    PubMed     Text format     Abstract available


    January 2017
  155. RUAN J, Chen Y, Zhou Y
    Development and Validation of a Questionnaire to Assess the Quality of Life in Patients with Inflammatory Bowel Disease in Mainland China.
    Inflamm Bowel Dis. 2017 Jan 26. doi: 10.1097/MIB.0000000000001024.
    PubMed     Text format     Abstract available


  156. FIORINO G, Manetti N, Armuzzi A, Orlando A, et al
    The PROSIT-BIO Cohort: A Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Infliximab Biosimilar.
    Inflamm Bowel Dis. 2017 Jan 12. doi: 10.1097/MIB.0000000000000995.
    PubMed     Text format     Abstract available


  157. KUCHARZIK T, Lemmnitz G, Abels C, Maaser C, et al
    Tripeptide K(D)PT Is Well Tolerated in Mild-to-moderate Ulcerative Colitis: Results from a Randomized Multicenter Study.
    Inflamm Bowel Dis. 2017 Jan 12. doi: 10.1097/MIB.0000000000001000.
    PubMed     Text format     Abstract available


  158. ABDALLA MI, Sandler RS, Kappelman MD, Martin CF, et al
    Prevalence and Impact of Inflammatory Bowel Disease-Irritable Bowel Syndrome on Patient-reported Outcomes in CCFA Partners.
    Inflamm Bowel Dis. 2017 Jan 12. doi: 10.1097/MIB.0000000000001017.
    PubMed     Text format     Abstract available


  159. QIN X
    Damage of the Mucus Layer: The Possible Shared Critical Common Cause for Both Inflammatory Bowel Disease (IBD) and Irritable Bowel Syndrome (IBS).
    Inflamm Bowel Dis. 2017 Jan 10. doi: 10.1097/MIB.0000000000001010.
    PubMed     Text format    


  160. KORELITZ BI, Shamah S
    The Ileitis of Ulcerative Colitis. Why Is It Not Crohn's Disease?
    Inflamm Bowel Dis. 2017 Jan 10. doi: 10.1097/MIB.0000000000001006.
    PubMed     Text format    


  161. SCHREINER P, Biedermann L, Rossel JB, Rogler G, et al
    Prevalence and Determinants of Job Stress in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Jan 10. doi: 10.1097/MIB.0000000000001012.
    PubMed     Text format     Abstract available


  162. COENEN S, Weyts E, Jorissen C, De Munter P, et al
    Effects of Education and Information on Vaccination Behavior in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Jan 10. doi: 10.1097/MIB.0000000000001013.
    PubMed     Text format     Abstract available


  163. CHEN Y, Furuya-Kanamori L, Doi SA, Ananthakrishnan AN, et al
    Clostridium difficile Infection and Risk of Colectomy in Patients with Inflammatory Bowel Disease: A Bias-adjusted Meta-analysis.
    Inflamm Bowel Dis. 2017 Jan 10. doi: 10.1097/MIB.0000000000000998.
    PubMed     Text format     Abstract available


  164. LEWIS JD, Albenberg L, Lee D, Kratz M, et al
    The Importance and Challenges of Dietary Intervention Trials for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Jan 10. doi: 10.1097/MIB.0000000000001009.
    PubMed     Text format     Abstract available


    December 2016
  165. NGUYEN GC, Bernstein CN, Benchimol EI
    Risk of Surgery and Mortality in Elderly-onset Inflammatory Bowel Disease: A Population-based Cohort Study.
    Inflamm Bowel Dis. 2016 Dec 16. doi: 10.1097/MIB.0000000000000993.
    PubMed     Text format     Abstract available


  166. RUBIN DT, Feld LD, Goeppinger SR, Margolese J, et al
    The Crohn's and Colitis Foundation of America Survey of Inflammatory Bowel Disease Patient Health Care Access.
    Inflamm Bowel Dis. 2016 Dec 16. doi: 10.1097/MIB.0000000000000994.
    PubMed     Text format     Abstract available


  167. HOU JK, Kramer JR, Richardson P, Sansgiry S, et al
    Tuberculosis Screening and Reactivation Among a National Cohort of Patients with Inflammatory Bowel Disease Treated with Tumor Necrosis Factor Alpha Antagonists.
    Inflamm Bowel Dis. 2016 Dec 16. doi: 10.1097/MIB.0000000000001003.
    PubMed     Text format     Abstract available


  168. FRIEDMAN S, Larsen PV, Fedder J, Norgard BM, et al
    The Efficacy of Assisted Reproduction in Women with Inflammatory Bowel Disease and the Impact of Surgery-A Nationwide Cohort Study.
    Inflamm Bowel Dis. 2016 Dec 16. doi: 10.1097/MIB.0000000000000996.
    PubMed     Text format     Abstract available


  169. SIVA S, Rubin DT, Gulotta G, Wroblewski K, et al
    Zinc Deficiency is Associated with Poor Clinical Outcomes in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  170. TAHARA T, Hirata I, Nakano N, Nagasaka M, et al
    Comprehensive DNA Methylation Profiling of Inflammatory Mucosa in Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  171. GRACIE DJ, Ford AC
    Ongoing Symptoms in Ulcerative Colitis Patients in Remission: Irritable Bowel Syndrome or Gastrointestinal Symptoms in the Absence of Inflammation?
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  172. HUANG C, De Ravin SS, Paul AR, Heller T, et al
    Genetic Risk for Inflammatory Bowel Disease Is a Determinant of Crohn's Disease Development in Chronic Granulomatous Disease.
    Inflamm Bowel Dis. 2016;22:2794-2801.
    PubMed     Text format     Abstract available


    November 2016
  173. CUI DJ, Yang XL, Hu M, Yang LC, et al
    Effects of Preoperative Methotrexate on Complications After Surgery for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  174. ISHIKAWA D, Sasaki T, Osada T, Kuwahara-Arai K, et al
    Changes in Intestinal Microbiota Following Combination Therapy with Fecal Microbial Transplantation and Antibiotics for Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  175. ROBINSON AM, Gondalia SV, Karpe AV, Eri R, et al
    Fecal Microbiota and Metabolome in a Mouse Model of Spontaneous Chronic Colitis: Relevance to Human Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  176. HUANG C, De Ravin SS, Paul AR, Heller T, et al
    Genetic Risk for Inflammatory Bowel Disease Is a Determinant of Crohn's Disease Development in Chronic Granulomatous Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  177. TAKESHITA K, Mizuno S, Mikami Y, Sujino T, et al
    A Single Species of Clostridium Subcluster XIVa Decreased in Ulcerative Colitis Patients.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  178. CALDERA F, Hayney MS
    Barriers to Administration of Herpes Zoster Immunization in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016;22:E44.
    PubMed     Text format    


  179. MOTTET C, Schoepfer AM, Juillerat P, Cosnes J, et al
    Experts Opinion on the Practical Use of Azathioprine and 6-Mercaptopurine in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016;22:2733-2747.
    PubMed     Text format     Abstract available


  180. HASHASH JG, Sigal R, Wein-Levy P, Szigethy EM, et al
    Inflammatory Bowel Disease (IBD) Connect: A Novel Volunteer Program for Hospitalized Patients with IBD and Their Families.
    Inflamm Bowel Dis. 2016;22:2748-2753.
    PubMed     Text format     Abstract available


  181. GIANOTTI RJ, Moss AC
    The Use and Efficacy of Fecal Microbiota Transplantation for Refractory Clostridium difficile in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016;22:2704-2710.
    PubMed     Text format     Abstract available


  182. REICH J, Guo L, Hall J, Tran A, et al
    A Survey of Social Media Use and Preferences in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016;22:2678-2687.
    PubMed     Text format     Abstract available


  183. COLLIJ V, Festen EA, Alberts R, Weersma RK, et al
    Drug Repositioning in Inflammatory Bowel Disease Based on Genetic Information.
    Inflamm Bowel Dis. 2016;22:2562-2570.
    PubMed     Text format     Abstract available


  184. TEW GA, Jones K, Mikocka-Walus A
    Physical Activity Habits, Limitations, and Predictors in People with Inflammatory Bowel Disease: A Large Cross-sectional Online Survey.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


    October 2016
  185. CHOY MC, Visvanathan K, De Cruz P
    An Overview of the Innate and Adaptive Immune System in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  186. BARNES EL, Burakoff R
    New Biomarkers for Diagnosing Inflammatory Bowel Disease and Assessing Treatment Outcomes.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  187. PALONE F, Vitali R, Cucchiara S, Mennini M, et al
    Fecal HMGB1 Reveals Microscopic Inflammation in Adult and Pediatric Patients with Inflammatory Bowel Disease in Clinical and Endoscopic Remission.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


    September 2016
  188. CHEN SW, Wang PY, Liu YC, Sun L, et al
    Effect of Long Noncoding RNA H19 Overexpression on Intestinal Barrier Function and Its Potential Role in the Pathogenesis of Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  189. CANEPARO V, Pastorelli L, Pisani LF, Bruni B, et al
    Distinct Anti-IFI16 and Anti-GP2 Antibodies in Inflammatory Bowel Disease and Their Variation with Infliximab Therapy.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  190. JONEFJALL B, Ohman L, Simren M, Strid H, et al
    IBS-like Symptoms in Patients with Ulcerative Colitis in Deep Remission Are Associated with Increased Levels of Serum Cytokines and Poor Psychological Well-being.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  191. QIN X
    Perinuclear Antineutrophil Cytoplasmic Antibody with a Large Portion Being Anti-beta-Glucuronidase, May Have Played a Causative Role in the Pathogenesis of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  192. ZITTAN E, Milgrom R, Ma GW, Wong-Chong N, et al
    Preoperative Anti-tumor Necrosis Factor Therapy in Patients with Ulcerative Colitis Is Not Associated with an Increased Risk of Infectious and Noninfectious Complications After Ileal Pouch-anal Anastomosis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  193. COTE-DAIGNEAULT J, Peerani F, MacMahon E, Delaporte E, et al
    Management and Prevention of Herpes Zoster in the Immunocompromised Inflammatory Bowel Disease Patient: A Clinical Quandary.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  194. CONRAD MA, Stein RE, Maxwell EC, Albenberg L, et al
    Vedolizumab Therapy in Severe Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  195. SEDGHI S, Barreau F, Morilla I, Montcuquet N, et al
    Increased Proliferation of the Ileal Epithelium as a Remote Effect of Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  196. TALABUR HORJE CS, Meijer J, Rovers L, van Lochem EG, et al
    Prevalence of Upper Gastrointestinal Lesions at Primary Diagnosis in Adults with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016;22:E33-4.
    PubMed     Text format    


  197. NOBEL T, Khaitov S, Greenstein AJ
    Controversies in J Pouch Surgery for Ulcerative Colitis: A Focus on Handsewn Versus Stapled Anastomosis.
    Inflamm Bowel Dis. 2016;22:2302-9.
    PubMed     Text format     Abstract available


  198. ABDUL-BAKI H, Greer JB, Binion DG, Kermanshahi TR, et al
    IBD LIVE Case Series-Case 5: The Many Faces of Cytomegalovirus in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016;22:2245-54.
    PubMed     Text format    


  199. BARNES EL, Beery RM, Schulman AR, McCarthy EP, et al
    Hospitalizations for Acute Myocardial Infarction Are Decreased Among Patients with Inflammatory Bowel Disease Using a Nationwide Inpatient Database.
    Inflamm Bowel Dis. 2016;22:2229-37.
    PubMed     Text format     Abstract available


  200. LEVY RL, van Tilburg MA, Langer SL, Romano JM, et al
    Effects of a Cognitive Behavioral Therapy Intervention Trial to Improve Disease Outcomes in Children with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016;22:2134-48.
    PubMed     Text format     Abstract available


  201. SINGH N, Rabizadeh S, Jossen J, Pittman N, et al
    Multi-Center Experience of Vedolizumab Effectiveness in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016;22:2121-6.
    PubMed     Text format     Abstract available


  202. GOFFIN L, Fagagnini S, Vicari A, Mamie C, et al
    Anti-MMP-9 Antibody: A Promising Therapeutic Strategy for Treatment of Inflammatory Bowel Disease Complications with Fibrosis.
    Inflamm Bowel Dis. 2016;22:2041-57.
    PubMed     Text format     Abstract available


    August 2016
  203. HAMILTON MJ, Makrauer FM, Golden K, Wang H, et al
    Prospective Evaluation of Terminal Ileitis in a Surveillance Population of Patients with Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  204. FISCHER M, Kao D, Kelly C, Kuchipudi A, et al
    Fecal Microbiota Transplantation is Safe and Efficacious for Recurrent or Refractory Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  205. KOPYLOV U, Boucher G, Waterman M, Rivers CR, et al
    Genetic Predictors of Benign Course of Ulcerative Colitis-A North American Inflammatory Bowel Disease Genetics Consortium Study.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  206. LIM TY, Pavlidis P, Gulati S, Pirani T, et al
    Vedolizumab in Inflammatory Bowel Disease Associated with Autoimmune Liver Disease Pre- and Postliver Transplantation: A Case Series.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  207. BENCHIMOL EI, Manuel DG, Mojaverian N, Mack DR, et al
    Health Services Utilization, Specialist Care, and Time to Diagnosis with Inflammatory Bowel Disease in Immigrants to Ontario, Canada: A Population-Based Cohort Study.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  208. ASHTON JJ, Andreoletti G, Coelho T, Haggarty R, et al
    Identification of Variants in Genes Associated with Single-gene Inflammatory Bowel Disease by Whole-exome Sequencing.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  209. GLOVER LE, Fennimore B, Wingfield M
    Inflammatory Bowel Disease: Influence and Implications in Reproduction.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  210. LEE WJ, Briars L, Lee TA, Calip GS, et al
    Top-down Versus Step-up Prescribing Strategies for Tumor Necrosis Factor Alpha Inhibitors in Children and Young Adults with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  211. HASOSAH M, Matrafi A, Jastaniah W, Alsahafi A, et al
    Pediatric Inflammatory Bowel Disease and Hereditary Hemolytic Anemia: A Retrospective Analysis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  212. MCDANIEL DK, Eden K, Ringel VM, Allen IC, et al
    Emerging Roles for Noncanonical NF-kappaB Signaling in the Modulation of Inflammatory Bowel Disease Pathobiology.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  213. GUERRERIO AL, Frischmeyer-Guerrerio PA, Huang C, Wu Y, et al
    Increased Prevalence of Inflammatory Bowel Disease in Patients with Mutations in Genes Encoding the Receptor Subunits for TGFbeta.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  214. JACKSON WE, Achkar JP, Macaron C, Lee L, et al
    The Significance of Sessile Serrated Polyps in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  215. LI R, Zheng J, Jiang M, Liu Y, et al
    Increased Digestive Proteases and Decreased beta-Glucuronidase in Feces of Rats Treated with Sucralose and Saccharin-Another Critical Evidence That These Dietary Chemicals May Be Important Causative Factors for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016;22:E29-30.
    PubMed     Text format    


  216. TAO Z, Qin Z
    Can Statins Be Used in Patients with Inflammatory Bowel Disease Regularly?
    Inflamm Bowel Dis. 2016;22:E28-9.
    PubMed     Text format    


  217. MATTHIS AL, Zhang B, Denson LA, Yacyshyn BR, et al
    Importance of the Evaluation of N-Acetyltransferase Enzyme Activity Prior to 5-Aminosalicylic Acid Medication for Ulcerative Colitis.
    Inflamm Bowel Dis. 2016;22:1793-802.
    PubMed     Text format     Abstract available


  218. NG SC, Leung WK, Shi HY, Li MK, et al
    Epidemiology of Inflammatory Bowel Disease from 1981 to 2014: Results from a Territory-Wide Population-Based Registry in Hong Kong.
    Inflamm Bowel Dis. 2016;22:1954-60.
    PubMed     Text format     Abstract available


  219. GOVANI SM, Wiitala WL, Stidham RW, Saini SD, et al
    Age Disparities in the Use of Steroid-sparing Therapy for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016;22:1923-8.
    PubMed     Text format     Abstract available


  220. REIGADA LC, Satpute A, Hoogendoorn CJ, Cohen BH, et al
    Patient-reported Anxiety: A Possible Predictor of Pediatric Inflammatory Bowel Disease Health Care Use.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  221. SEVERS M, Zuithoff PN, Mangen MJ, van der Valk ME, et al
    Assessing Self-reported Medication Adherence in Inflammatory Bowel Disease: A Comparison of Tools.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  222. SU HY, Gupta V, Day AS, Gearry RB, et al
    Rising Incidence of Inflammatory Bowel Disease in Canterbury, New Zealand.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  223. HOU JK, Feagins LA, Waljee AK
    Characteristics and Behavior of Elderly-onset Inflammatory Bowel Disease: A Multi-center US Study.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  224. VAN ASSELDONK DP, Jharap B, Verheij J, den Hartog G, et al
    The Prevalence of Nodular Regenerative Hyperplasia in Inflammatory Bowel Disease Patients Treated with Thioguanine Is Not Associated with Clinically Significant Liver Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


    July 2016
  225. KOCHHAR G, Singh T, Dust H, Lopez R, et al
    Impact of De Novo and Preexisting Inflammatory Bowel Disease on the Outcome of Orthotopic Liver Transplantation.
    Inflamm Bowel Dis. 2016;22:1670-8.
    PubMed     Text format     Abstract available


  226. ABDUL SULTAN A, West J, Ban L, Humes D, et al
    Adverse Pregnancy Outcomes Among Women with Inflammatory Bowel Disease: A Population-Based Study from England.
    Inflamm Bowel Dis. 2016;22:1621-30.
    PubMed     Text format     Abstract available


  227. DOTSON JL, Falaiye T, Bricker JB, Strople J, et al
    North American Pediatric Gastroenterology Fellowship Needs Assessment in Inflammatory Bowel Disease: Trainee and Program Director Perspectives.
    Inflamm Bowel Dis. 2016;22:1616-20.
    PubMed     Text format     Abstract available


  228. COHEN BL, Ha C, Ananthakrishnan AN, Rieder F, et al
    State of Adult Trainee Inflammatory Bowel Disease Education in the United States: A National Survey.
    Inflamm Bowel Dis. 2016;22:1609-15.
    PubMed     Text format     Abstract available


  229. TOM MR, Li J, Ueno A, Fort Gasia M, et al
    Novel CD8+ T-Cell Subsets Demonstrating Plasticity in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016;22:1596-608.
    PubMed     Text format     Abstract available


  230. AFZALI A, Cross RK
    Racial and Ethnic Minorities with Inflammatory Bowel Disease in the United States: A Systematic Review of Disease Characteristics and Differences.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  231. BESSISSOW T, Le NH, Rollet K, Afif W, et al
    Incidence and Predictors of Nonalcoholic Fatty Liver Disease by Serum Biomarkers in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


    June 2016
  232. MITSUHASHI S, Feldbrugge L, Csizmadia E, Mitsuhashi M, et al
    Luminal Extracellular Vesicles (EVs) in Inflammatory Bowel Disease (IBD) Exhibit Proinflammatory Effects on Epithelial Cells and Macrophages.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  233. SCAIOLI E, Digby RJ, Belluzzi A
    Different Cutoff Levels of Fecal Calprotectin to Predict Clinical Relapse in Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  234. CONROY G, Clerc-Urmes I, Allen PB, Baumann C, et al
    What Proportion of Patients With Inflammatory Bowel Disease Want to Stop Infliximab Therapy?
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  235. LIMDI JK
    Rectal Therapy in Ulcerative Colitis: Science and Sensitivity.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  236. SMOLINSKA S, Groeger D, Perez NR, Schiavi E, et al
    Histamine Receptor 2 is Required to Suppress Innate Immune Responses to Bacterial Ligands in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  237. ALOI M, D'Arcangelo G, Bramuzzo M, Gasparetto M, et al
    Effect of Early Versus Late Azathioprine Therapy in Pediatric Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  238. PAVLIDIS P, Stamoulos P, Abdulrehman A, Kerr P, et al
    Long-term Safety and Efficacy of Low-dose Azathioprine and Allopurinol Cotherapy in Inflammatory Bowel Disease: A Large Observational Study.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  239. RESTALL GJ, Simms AM, Walker JR, Graff LA, et al
    Understanding Work Experiences of People with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


    May 2016
  240. GREN ST, Grip O
    Role of Monocytes and Intestinal Macrophages in Crohn's Disease and Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  241. LI J, Ueno A, Fort Gasia M, Luider J, et al
    Profiles of Lamina Propria T Helper Cell Subsets Discriminate Between Ulcerative Colitis and Crohn's Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  242. ANDREWS C, McLean MH, Durum SK
    Interleukin-27 as a Novel Therapy for Inflammatory Bowel Disease: A Critical Review of the Literature.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  243. SUBRAMANIAN S, Asher R, Weston W, Rimmer M, et al
    Validation of a Simple 0 to 10 Numerical Score (IBD-10) of Patient-reported Inflammatory Bowel Disease Activity for Routine Clinical Use.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  244. LOPETUSO LR, Ianiro G, Scaldaferri F, Cammarota G, et al
    Gut Virome and Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  245. HUPPERTZ-HAUSS G, Lie Hoivik M, Jelsness-Jorgensen LP, Henriksen M, et al
    Health-related Quality of Life in Patients with Inflammatory Bowel Disease 20 Years After Diagnosis: Results from the IBSEN Study.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  246. REININK AR, Lee TC, Higgins PD
    Endoscopic Mucosal Healing Predicts Favorable Clinical Outcomes in Inflammatory Bowel Disease: A Meta-analysis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  247. RIEDER F, Cohen BL, Dotson JL, Bewtra M, et al
    Rising Educators, Academicians, and Clinicians Helping Inflammatory Bowel Disease-Promoting Improvement of Inflammatory Bowel Disease Education in the United States.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  248. HOPKINS CW, Moulton CD
    Is it Premature to Advocate Systematic Psychological Screening for Patients with Inflammatory Bowel Disease?
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  249. DEGRUTTOLA AK, Low D, Mizoguchi A, Mizoguchi E, et al
    Current Understanding of Dysbiosis in Disease in Human and Animal Models.
    Inflamm Bowel Dis. 2016;22:1137-50.
    PubMed     Text format     Abstract available


  250. DONEGAN A, Boyle B, Crandall W, Dotson JL, et al
    Connecting Families: A Pediatric IBD Center's Development and Implementation of a Volunteer Parent Mentor Program.
    Inflamm Bowel Dis. 2016;22:1151-6.
    PubMed     Text format     Abstract available


  251. GREENUP AJ, Bressler B, Rosenfeld G
    Medical Imaging in Small Bowel Crohn's Disease-Computer Tomography Enterography, Magnetic Resonance Enterography, and Ultrasound: "Which One Is the Best for What?".
    Inflamm Bowel Dis. 2016;22:1246-61.
    PubMed     Text format     Abstract available


  252. GANZ ML, Sugarman R, Wang R, Hansen BB, et al
    The Economic and Health-related Impact of Crohn's Disease in the United States: Evidence from a Nationally Representative Survey.
    Inflamm Bowel Dis. 2016;22:1032-41.
    PubMed     Text format     Abstract available


  253. CALABRESE E, Maaser C, Zorzi F, Kannengiesser K, et al
    Bowel Ultrasonography in the Management of Crohn's Disease. A Review with Recommendations of an International Panel of Experts.
    Inflamm Bowel Dis. 2016;22:1168-83.
    PubMed     Text format     Abstract available


  254. SEHGAL P, Colombel JF, Narula N
    Adverse Events During Anti-TNFalpha Therapies in IBD (Excluding Infections and Malignancies): When to Stop, Continue, or Switch Therapies.
    Inflamm Bowel Dis. 2016;22:1239-45.
    PubMed     Text format     Abstract available


  255. SAAD AM, Czul F, Sakuraba A, Rubin DT, et al
    Age of Diagnosis is Associated with Disease Presentation and Therapeutic Complications in Patients with Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:1027-31.
    PubMed     Text format     Abstract available


  256. FLASAR MH, Chao J, Ozbay AB, Skup M, et al
    Biological and Immunomodulator Use in Crohn's Disease in a Medicaid Population.
    Inflamm Bowel Dis. 2016;22:1056-64.
    PubMed     Text format     Abstract available


  257. CHACHU KA, Osterman MT
    How to Diagnose and Treat IBD Mimics in the Refractory IBD Patient Who Does Not Have IBD.
    Inflamm Bowel Dis. 2016;22:1262-74.
    PubMed     Text format     Abstract available


  258. HAYASHI R, Tsuchiya K, Fukushima K, Horita N, et al
    Reduced Human alpha-defensin 6 in Noninflamed Jejunal Tissue of Patients with Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:1119-28.
    PubMed     Text format     Abstract available


  259. INOKUCHI T, Kato J, Hiraoka S, Takashima S, et al
    Fecal Immunochemical Test Versus Fecal Calprotectin for Prediction of Mucosal Healing in Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:1078-85.
    PubMed     Text format     Abstract available


  260. CHEN ML, Sundrud MS
    Cytokine Networks and T-Cell Subsets in Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2016;22:1157-67.
    PubMed     Text format     Abstract available


  261. GALE G, Sigurdsson GV, Ostman S, Malmborg P, et al
    Does Crohn's Disease with Concomitant Orofacial Granulomatosis Represent a Distinctive Disease Subtype?
    Inflamm Bowel Dis. 2016;22:1071-7.
    PubMed     Text format     Abstract available


  262. LIMKETKAI BN, Parian AM, Shah ND, Colombel JF, et al
    Short Bowel Syndrome and Intestinal Failure in Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:1209-18.
    PubMed     Text format     Abstract available


  263. MURAWSKA N, Fabisiak A, Fichna J
    Anemia of Chronic Disease and Iron Deficiency Anemia in Inflammatory Bowel Diseases: Pathophysiology, Diagnosis, and Treatment.
    Inflamm Bowel Dis. 2016;22:1198-208.
    PubMed     Text format     Abstract available


  264. WRIGHT EK, Kamm MA, De Cruz P, Hamilton AL, et al
    Comparison of Fecal Inflammatory Markers in Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:1086-94.
    PubMed     Text format     Abstract available


    April 2016
  265. MIKOCKA-WALUS A, Knowles SR, Keefer L, Graff L, et al
    Addressing Psychological Needs of Individuals with Inflammatory Bowel Disease Is Necessary.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  266. REGUEIRO MD, McAnallen SE, Greer JB, Perkins SE, et al
    The Inflammatory Bowel Disease Specialty Medical Home: A New Model of Patient-centered Care.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  267. GARRITY-PARK MM, Loftus EV Jr, Bryant SC, Smyrk TC, et al
    A Biomarker Panel to Detect Synchronous Neoplasm in Non-neoplastic Surveillance Biopsies from Patients with Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  268. SUN L, Wang W, Xiao W, Yang H, et al
    The Roles of Cathelicidin LL-37 in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  269. STEENHOLDT C, Bendtzen K, Brynskov J, Ainsworth MA, et al
    Optimizing Treatment with TNF Inhibitors in Inflammatory Bowel Disease by Monitoring Drug Levels and Antidrug Antibodies.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  270. CASALS-SEOANE F, Chaparro M, Mate J, Gisbert JP, et al
    Clinical Course of Bone Metabolism Disorders in Patients with Inflammatory Bowel Disease: A 5-Year Prospective Study.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  271. BIRIMBERG-SCHWARTZ L, Wilson DC, Kolho KL, Karolewska-Bochenek K, et al
    pANCA and ASCA in Children with IBD-Unclassified, Crohn's Colitis, and Ulcerative Colitis-A Longitudinal Report from the IBD Porto Group of ESPGHAN.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  272. HEYBELI C
    The Complement System and Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  273. RAO K, Higgins PD
    Epidemiology, Diagnosis, and Management of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  274. NGUYEN GC, Croitoru K, Silverberg MS, Steinhart AH, et al
    Use of Complementary and Alternative Medicine for Inflammatory Bowel Disease Is Associated with Worse Adherence to Conventional Therapy: The COMPLIANT Study.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  275. YAMMINE S, Nyilas S, Casaulta C, Schibli S, et al
    Function and Ventilation of Large and Small Airways in Children and Adolescents with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  276. OPSTELTEN JL, Leenders M, Dik VK, Chan SS, et al
    Dairy Products, Dietary Calcium, and Risk of Inflammatory Bowel Disease: Results From a European Prospective Cohort Investigation.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  277. WEISSHOF R, Ungar B, Blatt A, Dahan A, et al
    Anti-infliximab Antibodies with Neutralizing Capacity in Patients with Inflammatory Bowel Disease: Distinct Clinical Implications Revealed by a Novel Assay.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  278. COBURN LA, Horst SN, Allaman MM, Brown CT, et al
    L-Arginine Availability and Metabolism Is Altered in Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  279. JOHNSON DH, Taylor WR, Aboelsoud MM, Foote PH, et al
    DNA Methylation and Mutation of Small Colonic Neoplasms in Ulcerative Colitis and Crohn's Colitis: Implications for Surveillance.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  280. JANECKE AR, Heinz-Erian P, Muller T
    Mechanisms Underlying Dysregulation of Electrolyte Absorption in Inflammatory Bowel Disease-Associated Diarrhea.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  281. YAGI S, Abe M, Yamashita M, Mori K, et al
    Carbonic Anhydrate I Epitope Peptide Improves Inflammation in a Murine Model of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  282. MANETTI N, Bagnoli S, Rogai F, Bonanomi AG, et al
    Disease Course and Colectomy Rate of Ulcerative Colitis: A Follow-up Cohort Study of a Referral Center in Tuscany.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  283. BIANCHERI P, Foster MR, Fyfe MC, MacDonald TT, et al
    Effect of Narrow Spectrum Versus Selective Kinase Inhibitors on the Intestinal Proinflammatory Immune Response in Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  284. AL-HUSSAINI A, El Mouzan M, Hasosah M, Al-Mehaidib A, et al
    Clinical Pattern of Early-Onset Inflammatory Bowel Disease in Saudi Arabia: A Multicenter National Study.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  285. LI J, Wei Z, Chang X, Cardinale CJ, et al
    Pathway-based Genome-wide Association Studies Reveal the Association Between Growth Factor Activity and Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  286. MESTROVIC T
    Leveling the Human Microbiota Playing Field: A Rederivation of Gut Bacteria to Human Cells Ratio in Physiological Conditions and in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  287. WU W, Chen F, Liu Z, Cong Y, et al
    Microbiota-specific Th17 Cells: Yin and Yang in Regulation of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  288. QIN X
    How Sugar and Soft Drinks Are Related to Inflammatory Bowel Disease?
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  289. HORJUS TALABUR HORJE CS, Meijer J, Rovers L, van Lochem EG, et al
    Prevalence of Upper Gastrointestinal Lesions at Primary Diagnosis in Adults with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  290. HERRERA-DEGUISE C, Casellas F, Robles V, Navarro E, et al
    Iron Deficiency in the Absence of Anemia Impairs the Perception of Health-Related Quality of Life of Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  291. AFZALI A, Park CJ, Zhu K, Hu JK, et al
    Preoperative Use of Methotrexate and the Risk of Early Postoperative Complications in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  292. DEVLIN SM, Melmed GY, Irving PM, Rubin DT, et al
    Recommendations for Quality Colonoscopy Reporting for Patients with Inflammatory Bowel Disease: Results from a RAND Appropriateness Panel.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  293. WASAN SK, Zullow S, Berg A, Cheifetz AS, et al
    Herpes Zoster Vaccine Response in Inflammatory Bowel Disease Patients on Low-dose Immunosuppression.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  294. BUCHNER AM, Lichtenstein GR
    How to Assess and Document Endoscopies in IBD Patients by Including Standard Scoring Systems.
    Inflamm Bowel Dis. 2016;22:1010-9.
    PubMed     Text format     Abstract available


  295. GILS A, Van Stappen T, Dreesen E, Storme R, et al
    Harmonization of Infliximab and Anti-Infliximab Assays Facilitates the Comparison Between Originators and Biosimilars in Clinical Samples.
    Inflamm Bowel Dis. 2016;22:969-75.
    PubMed     Text format     Abstract available


  296. DUBINSKY MC, Rosh J, Faubion WA Jr, Kierkus J, et al
    Efficacy and Safety of Escalation of Adalimumab Therapy to Weekly Dosing in Pediatric Patients with Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:886-93.
    PubMed     Text format     Abstract available


  297. KAUR M, Panikkath D, Yan X, Liu Z, et al
    Perianal Crohn's Disease is Associated with Distal Colonic Disease, Stricturing Disease Behavior, IBD-Associated Serologies and Genetic Variation in the JAK-STAT Pathway.
    Inflamm Bowel Dis. 2016;22:862-9.
    PubMed     Text format     Abstract available


  298. VERGARA M, Sicilia B, Prieto L, Casellas F, et al
    Development and Validation of the Short Crohn's Disease Work Disability Questionnaire.
    Inflamm Bowel Dis. 2016;22:955-62.
    PubMed     Text format     Abstract available


  299. JUNG ES, Cheon JH, Lee JH, Park SJ, et al
    HLA-C*01 is a Risk Factor for Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:796-806.
    PubMed     Text format     Abstract available


  300. MA C, Beilman CL, Huang VW, Fedorak DK, et al
    Anti-TNF Therapy Within 2 Years of Crohn's Disease Diagnosis Improves Patient Outcomes: A Retrospective Cohort Study.
    Inflamm Bowel Dis. 2016;22:870-9.
    PubMed     Text format     Abstract available


    March 2016
  301. QIN X
    Is Colonic Crohn's Disease More Closely Related to Ulcerative Colitis or Crohn's Disease by Nature?
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  302. QIN X
    The Possible Link Between Artificial Sweeteners Such as Saccharin and Sucralose and Inflammatory Bowel Disease Deserves Further Study.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  303. GEISZ M, Ha C, Kappelman MD, Martin CF, et al
    Medication Utilization and the Impact of Continued Corticosteroid Use on Patient-reported Outcomes in Older Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  304. BRANDSE JF, Bennink RJ, van Eeden S, Lowenberg M, et al
    Performance of Common Disease Activity Markers as a Reflection of Inflammatory Burden in Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  305. KOH SZ, Zaghiyan KN, Li Q, Rabizadeh S, et al
    Clinical Factors Associated with the Development of Crohn's Disease in Inflammatory Bowel Disease-unclassified Patients Undergoing Ileal Pouch-anal Anastomosis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  306. TYLER AD, Kirsch R, Milgrom R, Stempak JM, et al
    Microbiome Heterogeneity Characterizing Intestinal Tissue and Inflammatory Bowel Disease Phenotype.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  307. HUGHES M, Qazi T, Berg A, Weinberg J, et al
    Host Immune Response to Clostridium difficile Infection in Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  308. CAO SS
    Epithelial ER Stress in Crohn's Disease and Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  309. CLICK B, Ramos Rivers C, Koutroubakis IE, Babichenko D, et al
    Demographic and Clinical Predictors of High Healthcare Use in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  310. THOMPSON KD, Connor SJ, Walls DM, Gollins J, et al
    Patients with Ulcerative Colitis Are More Concerned About Complications of Their Disease than Side Effects of Medications.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  311. WU F, Huang Y, Dong F, Kwon JH, et al
    Ulcerative Colitis-Associated Long Noncoding RNA, BC012900, Regulates Intestinal Epithelial Cell Apoptosis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  312. FORBES JD, Van Domselaar G, Bernstein CN
    Microbiome Survey of the Inflamed and Noninflamed Gut at Different Compartments Within the Gastrointestinal Tract of Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  313. SIMIAN D, Flores L, Ibanez P, Figueroa C, et al
    O-025 Disease-Related Knowledge in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016;22 Suppl 1:S9.
    PubMed     Text format     Abstract available


  314. MORGAN P, Siegle L, Huggins J
    O-024 Improving Pneumococcal Immunization Rates Among Immunocompromised Adolescent Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016;22 Suppl 1:S8-S9.
    PubMed     Text format     Abstract available


  315. MCBRIDE R
    O-023 YI Impact of Dedicated Inflammatory Bowel Disease (IBD) Clinic on IBD-Related Hospitalizations at Veterans Hospital.
    Inflamm Bowel Dis. 2016;22 Suppl 1:S8.
    PubMed     Text format     Abstract available


  316. PLANTZ K, Maxwell E, Mamula P, Baldassano R, et al
    O-022 Intravenous Iron Sucrose for Treatment of Iron Deficiency Anemia in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016;22 Suppl 1:S8.
    PubMed     Text format     Abstract available


  317. GRANT A, Kappelman M, Martin C, Otley A, et al
    O-021 A New Domain Structure for the IMPACT-III, a Pediatric Inflammatory Bowel Disease (IBD) Health Reported Quality of Life (HRQOL) Tool.
    Inflamm Bowel Dis. 2016;22 Suppl 1:S7-S8.
    PubMed     Text format     Abstract available


  318. VIENNOIS E, Zhao Y, Zhang M, Han M, et al
    O-016 YI Longitudinal Study of Circulating miRNA Biomarkers in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016;22 Suppl 1:S6.
    PubMed     Text format     Abstract available


  319. JEURING SF, van den Heuvel TR, Zeegers MP, Hameeteman WH, et al
    Epidemiology and Long-term Outcome of Inflammatory Bowel Disease Diagnosed at Elderly Age-An Increasing Distinct Entity?
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  320. ANANTHAKRISHNAN AN, Cagan A, Cai T, Gainer VS, et al
    Comparative Effectiveness of Infliximab and Adalimumab in Crohn's Disease and Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  321. GUERRA I, Perez-Jeldres T, Iborra M, Algaba A, et al
    Incidence, Clinical Characteristics, and Management of Psoriasis Induced by Anti-TNF Therapy in Patients with Inflammatory Bowel Disease: A Nationwide Cohort Study.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  322. WOLF DC
    Biosimilars in Crohn's Disease and Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  323. BHASIN S, Singh H, Targownik LE, Israeli E, et al
    Rates and Reasons for Nonuse of Prescription Medication for Inflammatory Bowel Disease in a Referral Clinic.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  324. MIKOCKA-WALUS A, Knowles SR, Keefer L, Graff L, et al
    Controversies Revisited: A Systematic Review of the Comorbidity of Depression and Anxiety with Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2016;22:752-62.
    PubMed     Text format     Abstract available


  325. WITTEN J, Siles R, Shen B, Yao Q, et al
    Triple Disease Combination: Familial Mediterranean Fever, Crohn's Disease, and Chronic Idiopathic Urticaria with Angioedema.
    Inflamm Bowel Dis. 2016;22:E12-3.
    PubMed     Text format    


  326. KRUGLIAK CLEVELAND N, Colman RJ, Rodriquez D, Hirsch A, et al
    Surveillance of IBD Using High Definition Colonoscopes Does Not Miss Adenocarcinoma in Patients with Low-grade Dysplasia.
    Inflamm Bowel Dis. 2016;22:631-7.
    PubMed     Text format     Abstract available


  327. KJELDSEN J, Nielsen J, Larsen MD, Qvist N, et al
    Postoperative Use of Anti-TNF-alpha Agents in Patients with Crohn's Disease and Risk of Reoperation-A Nationwide Cohort Study.
    Inflamm Bowel Dis. 2016;22:599-606.
    PubMed     Text format     Abstract available


  328. ROY A, Lichtiger S
    Clostridium difficile Infection: A Rarity in Patients Receiving Chronic Antibiotic Treatment for Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:648-53.
    PubMed     Text format     Abstract available


  329. CARRIERE J, Bretin A, Darfeuille-Michaud A, Barnich N, et al
    Exosomes Released from Cells Infected with Crohn's Disease-associated Adherent-Invasive Escherichia coli Activate Host Innate Immune Responses and Enhance Bacterial Intracellular Replication.
    Inflamm Bowel Dis. 2016;22:516-28.
    PubMed     Text format     Abstract available


  330. CLEYNEN I, Konings P, Robberecht C, Laukens D, et al
    Genome-Wide Copy Number Variation Scan Identifies Complement Component C4 as Novel Susceptibility Gene for Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:505-15.
    PubMed     Text format     Abstract available


  331. CHOI SH, Kim KW, Lee JY, Kim KJ, et al
    Diffusion-weighted Magnetic Resonance Enterography for Evaluating Bowel Inflammation in Crohn's Disease: A Systematic Review and Meta-analysis.
    Inflamm Bowel Dis. 2016;22:669-79.
    PubMed     Text format     Abstract available


  332. SAMAAN MA, de Jong D, Sahami S, Morgan S, et al
    Incidence and Severity of Prepouch Ileitis: A Distinct Disease Entity or a Manifestation of Refractory Pouchitis?
    Inflamm Bowel Dis. 2016;22:662-8.
    PubMed     Text format     Abstract available


    February 2016
  333. GAIDOS JK, Bickston SJ
    How to Optimize Colon Cancer Surveillance in Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  334. SHAPIRO JM, Zoega H, Shah SA, Bright RM, et al
    Incidence of Crohn's Disease and Ulcerative Colitis in Rhode Island: Report from the Ocean State Crohn's and Colitis Area Registry.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  335. ROSA A, Abrantes P, Sousa I, Francisco V, et al
    Ulcerative Colitis Is Under Dual (Mitochondrial and Nuclear) Genetic Control.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  336. LIN JC, Lin CS, Hsu CW, Lin CL, et al
    Association Between Parkinson's Disease and Inflammatory Bowel Disease: a Nationwide Taiwanese Retrospective Cohort Study.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  337. THEEDE K, Holck S, Ibsen P, Kallemose T, et al
    Fecal Calprotectin Predicts Relapse and Histological Mucosal Healing in Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  338. POULLENOT F, Seksik P, Beaugerie L, Amiot A, et al
    Risk of Incident Cancer in Inflammatory Bowel Disease Patients Starting Anti-TNF Therapy While Having Recent Malignancy.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  339. PRINCE AC, Myers CE, Joyce T, Irving P, et al
    Fermentable Carbohydrate Restriction (Low FODMAP Diet) in Clinical Practice Improves Functional Gastrointestinal Symptoms in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  340. ALEXOFF A, Roginsky G, Zhou Y, Kalenda M, et al
    Inpatient Costs for Patients with Inflammatory Bowel Disease and Acute Pancreatitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  341. GUO L, Reich J, Groshek J, Farraye FA, et al
    Social Media Use in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  342. SKOWRON KB, Lapin B, Rubin M, Hurst RD, et al
    Clostridium Difficile Infection in Ulcerative Colitis: Can Alteration of the Gut-associated Microbiome Contribute to Pouch Failure?
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  343. KAO CC, Lin CL, Huang WY, Cha TL, et al
    Association Between Inflammatory Bowel Disease and Erectile Dysfunction: A Nationwide Population-Based Study.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  344. LIMDI JK, Aggarwal D, McLaughlin JT
    Diet and Exacerbation of Inflammatory Bowel Disease Symptoms-Food for Thought.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  345. ROSEN D, Annunziato R, Colombel JF, Dubinsky M, et al
    Transition of Inflammatory Bowel Disease Care: Assessment of Transition Readiness Factors and Disease Outcomes in a Young Adult Population.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  346. DULAI PS, Singh S, Casteele NV, Boland BS, et al
    How Will Evolving Future Therapies and Strategies Change How We Position the Use of Biologics in Moderate to Severely Active Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  347. SEVERS M, Petersen RE, Siersema PD, Mangen MJ, et al
    Self-reported Health Care Utilization of Patients with Inflammatory Bowel Disease Correlates Perfectly with Medical Records.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  348. BHARADWAJ S, Shen B
    Therapeutic Armamentarium for Stricturing Crohn's Disease: Medical Versus Endoscopic Versus Surgical Approaches.
    Inflamm Bowel Dis. 2016;22:E7-8.
    PubMed     Text format    


  349. ALASTRUEY CL, Andujar Murcia X, Esteve Comas M
    Therapeutic Armamentarium for Stricturing Crohn's Disease: Medical Versus Endoscopic Versus Surgical Approaches.
    Inflamm Bowel Dis. 2016;22:E6.
    PubMed     Text format    


  350. MONIF GR
    Translation of Hypothesis to Therapy in Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:E8-9.
    PubMed     Text format    


  351. WALTER JG, Kahn SA, Noe JD, Schurman JV, et al
    Feeling Fine: Anxiety and Depressive Symptoms in Youth with Established IBD.
    Inflamm Bowel Dis. 2016;22:402-8.
    PubMed     Text format     Abstract available


  352. MIKOCKA-WALUS A, Andrews JM, Bampton P
    Cognitive Behavioral Therapy for IBD.
    Inflamm Bowel Dis. 2016;22:E5-6.
    PubMed     Text format    


  353. SORRENTINO D
    Preclinical and Undiagnosed Crohn's Disease: The Submerged Iceberg.
    Inflamm Bowel Dis. 2016;22:476-86.
    PubMed     Text format     Abstract available


  354. HARRIS KA, Horst S, Gadani A, Nohl A, et al
    Patients with Refractory Crohn's Disease Successfully Treated with Ustekinumab.
    Inflamm Bowel Dis. 2016;22:397-401.
    PubMed     Text format     Abstract available


  355. GRAY WN, Maddux MH
    Current Transition Practices in Pediatric IBD: Findings from a National Survey of Pediatric Providers.
    Inflamm Bowel Dis. 2016;22:372-9.
    PubMed     Text format     Abstract available


  356. DUCHATELLIER CF, Kumar R, Krupoves A, Braegger C, et al
    Steroid Administration and Growth Impairment in Children with Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:355-63.
    PubMed     Text format     Abstract available


  357. NAFTALI T, Reshef L, Kovacs A, Porat R, et al
    Distinct Microbiotas are Associated with Ileum-Restricted and Colon-Involving Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:293-302.
    PubMed     Text format     Abstract available


  358. OCHOA-CORTES F, Turco F, Linan-Rico A, Soghomonyan S, et al
    Enteric Glial Cells: A New Frontier in Neurogastroenterology and Clinical Target for Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2016;22:433-49.
    PubMed     Text format     Abstract available


  359. SUNADA K, Shinozaki S, Nagayama M, Yano T, et al
    Long-term Outcomes in Patients with Small Intestinal Strictures Secondary to Crohn's Disease After Double-balloon Endoscopy-assisted Balloon Dilation.
    Inflamm Bowel Dis. 2016;22:380-6.
    PubMed     Text format     Abstract available


  360. MENYS A, Makanyanga J, Plumb A, Bhatnagar G, et al
    Aberrant Motility in Unaffected Small Bowel is Linked to Inflammatory Burden and Patient Symptoms in Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:424-32.
    PubMed     Text format     Abstract available


  361. GAWRON LM, Sanders J, Steele KP, Flynn AD, et al
    Reproductive Planning and Contraception for Women with Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2016;22:459-64.
    PubMed     Text format     Abstract available


  362. GOLAN D, Gross B, Miller A, Klil-Drori S, et al
    Cognitive Function of Patients with Crohn's Disease is Associated with Intestinal Disease Activity.
    Inflamm Bowel Dis. 2016;22:364-71.
    PubMed     Text format     Abstract available


    January 2016
  363. LEE HS, Park SH, Kim SH, Kim J, et al
    Risk Factors and Clinical Outcomes Associated with Cytomegalovirus Colitis in Patients with Acute Severe Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  364. ZITTAN E, Kelly OB, Kirsch R, Milgrom R, et al
    Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  365. PROSBERG MV, Vester-Andersen MK, Andersson M, Jess T, et al
    Long-term Compliance with Oral 5-aminosalicylic Acid Therapy and Risk of Disease Recurrence in Patients with Ulcerative Colitis: A Population-based Cohort Study.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  366. SANTOS-ANTUNES J, Nunes AC, Lopes S, Macedo G, et al
    The Relevance of Vitamin D and Antinuclear Antibodies in Patients with Inflammatory Bowel Disease Under Anti-TNF Treatment: A Prospective Study.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  367. REED-KNIGHT B, Lee JL, Greenley RN, Lewis JD, et al
    Disease Activity Does Not Explain It All: How Internalizing Symptoms and Caregiver Depressive Symptoms Relate to Health-related Quality of Life Among Youth with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  368. SHAH ED, Siegel CA, Chong K, Melmed GY, et al
    Evaluating Study Withdrawal Among Biologics and Immunomodulators in Treating Ulcerative Colitis: A Meta-analysis of Controlled Clinical Trials.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  369. COTE-DAIGNEAULT J, Mehandru S, Ungaro R, Atreja A, et al
    Potential Immunomodulatory Effects of Statins in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  370. EPPINGA H, Peppelenbosch MP
    Worsening of Bowel Symptoms Through Diet in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  371. AGUAS M, Del Hoyo J, Faubel R, Nos P, et al
    Telemedicine in Inflammatory Bowel Disease: Opportunity Ahead.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  372. YARUR AJ, Jain A, Hauenstein SI, Quintero MA, et al
    Higher Adalimumab Levels Are Associated with Histologic and Endoscopic Remission in Patients with Crohn's Disease and Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  373. BERES NJ, Szabo D, Kocsis D, Szucs D, et al
    Role of Altered Expression of miR-146a, miR-155, and miR-122 in Pediatric Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  374. CARROLL MW, Hamilton Z, Gill H, Simkin J, et al
    Pediatric Inflammatory Bowel Disease Among South Asians Living in British Columbia, Canada: A Distinct Clinical Phenotype.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  375. PIERDOMENICO M, Cesi V, Cucchiara S, Vitali R, et al
    NOD2 Is Regulated By Mir-320 in Physiological Conditions but this Control Is Altered in Inflamed Tissues of Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  376. NISHIDA A, Hidaka K, Kanda T, Imaeda H, et al
    Increased Expression of Interleukin-36, a Member of the Interleukin-1 Cytokine Family, in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  377. BETTENWORTH D, Rieder F
    Reversibility of Stricturing Crohn's Disease-Fact or Fiction?
    Inflamm Bowel Dis. 2016;22:241-7.
    PubMed     Text format     Abstract available


  378. VAZEILLE E, Chassaing B, Buisson A, Dubois A, et al
    GipA Factor Supports Colonization of Peyer's Patches by Crohn's Disease-associated Escherichia Coli.
    Inflamm Bowel Dis. 2016;22:68-81.
    PubMed     Text format     Abstract available


  379. HERFARTH HH, Kappelman MD, Long MD, Isaacs KL, et al
    Use of Methotrexate in the Treatment of Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2016;22:224-33.
    PubMed     Text format     Abstract available


  380. MCCONNELL RA, Mahadevan U
    Use of Immunomodulators and Biologics Before, During, and After Pregnancy.
    Inflamm Bowel Dis. 2016;22:213-23.
    PubMed     Text format     Abstract available


  381. REICH KM, Fedorak RN, Madsen K, Kroeker KI, et al
    Role of Vitamin D in Infliximab-induced Remission in Adult Patients with Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:92-9.
    PubMed     Text format     Abstract available


  382. MANCINA RM, Spagnuolo R, Milano M, Brogneri S, et al
    PNPLA3 148M Carriers with Inflammatory Bowel Diseases Have Higher Susceptibility to Hepatic Steatosis and Higher Liver Enzymes.
    Inflamm Bowel Dis. 2016;22:134-40.
    PubMed     Text format     Abstract available


  383. ZUO L, Li Y, Zhu W, Shen B, et al
    Mesenteric Adipocyte Dysfunction in Crohn's Disease is Associated with Hypoxia.
    Inflamm Bowel Dis. 2016;22:114-26.
    PubMed     Text format     Abstract available


    December 2015
  384. TAMBUWALA MM
    Natural Nuclear Factor Kappa Beta Inhibitors: Safe Therapeutic Options for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  385. THARIAN B, George N, Navaneethan U
    Endoscopy in the Diagnosis and Management of Complications of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  386. SPOENDLIN J, Karatas G, Furlano RI, Jick SS, et al
    Rosacea in Patients with Ulcerative Colitis and Crohn's Disease: A Population-based Case-control Study.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  387. RACINE A, Carbonnel F, Chan SS, Hart AR, et al
    Dietary Patterns and Risk of Inflammatory Bowel Disease in Europe: Results from the EPIC Study.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  388. HOURIGAN SK, Sears CL, Oliva-Hemker M
    Clostridium difficile Infection in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  389. WINTER R, Norgard BM, Friedman S
    Treatment of the Pregnant Patient with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  390. KAPLAN M, Yuksel M, Ates I, Yaln Kilic ZM, et al
    Are sTWEAK and IL-17A Levels in Inflammatory Bowel Disease Associated with Disease Activity and Etiopathogenesis?
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  391. SUNSERI WM, Kugathasan S, Keljo DJ, Greer JB, et al
    IBD LIVE Case Series-Case 3: Very Early-Onset Inflammatory Bowel Disease: When Genetic Testing Proves Beneficial.
    Inflamm Bowel Dis. 2015;21:2958-2968.
    PubMed     Text format    


  392. ISAACS KL, Arora S
    Navigating the Affordable Care Act and the Patient with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015;21:2969-74.
    PubMed     Text format     Abstract available


  393. PRIYAMVADA S, Gomes R, Gill RK, Saksena S, et al
    Mechanisms Underlying Dysregulation of Electrolyte Absorption in Inflammatory Bowel Disease-Associated Diarrhea.
    Inflamm Bowel Dis. 2015;21:2926-35.
    PubMed     Text format     Abstract available


  394. HIEJIMA E, Nakase H, Heike T
    Reply: To PMID 25946569.
    Inflamm Bowel Dis. 2015;21:E30-1.
    PubMed     Text format    


    November 2015
  395. LASCURAIN L, Jensen MK, Guthery SL, Holmen J, et al
    Inflammatory Bowel Disease Phenotype in Pediatric Primary Sclerosing Cholangitis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  396. LONG MD, Weaver K, Kappelman MD, Herfarth HH, et al
    Photosensitivity to Ultraviolet Light in Patients with Inflammatory Bowel Disease Newly Initiating Immunosuppressive Therapy.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format    


  397. AHN HS
    Reply to: Food Additives Should Not be Ruled Out as the Possible Causative Factors of Inflammatory Bowel Disease in Korea.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format    


  398. TORMEY LK, Farraye FA, PaascheOrlow MK
    Understanding Health Literacy and its Impact on Delivering Care to Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  399. AHMED S, Melmed G, McGovern D, Robbins LA, et al
    Nonbloody Diarrhea but Not Significant Weight Loss at Diagnosis Is Associated with the Development of Denovo Crohn's Disease After Ileal Pouch-anal Anastomosis for Ulcerative Colitis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  400. DEBRUYN J, Fonseca K, Ghosh S, Panaccione R, et al
    Immunogenicity of Influenza Vaccine for Patients with Inflammatory Bowel Disease on Maintenance Infliximab Therapy: A Randomized Trial.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  401. LOPEZ-SILES M, Martinez-Medina M, Suris-Valls R, Aldeguer X, et al
    Changes in the Abundance of Faecalibacterium prausnitzii Phylogroups I and II in the Intestinal Mucosa of Inflammatory Bowel Disease and Patients with Colorectal Cancer.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  402. SANDS BE, Joshi S, Haddad J, Freudenberg JM, et al
    Assessing Colonic Exposure, Safety, and Clinical Activity of SRT2104, a Novel Oral SIRT1 Activator, in Patients with Mild to Moderate Ulcerative Colitis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  403. QIN X
    Food Additives Should Not Be Ruled Out as the Possible Causative Factors of Inflammatory Bowel Disease in Korea.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format    


  404. HINKS TS
    Reduced Numbers and Proapoptotic Features of Mucosal-associated Invariant T Cells as a Characteristic Finding in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format    


  405. CHANDE N, Marshall JK, Seow CH, Sandborn WJ, et al
    New Applications for Traditional Drugs in Inflammatory Bowel Disease: What Do Cochrane Reviews Tell Us?
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  406. SRINATH AI, Gupta N, Husain SZ
    Probing the Association of Pancreatitis in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  407. VINDING KK, Elsberg H, Thorkilgaard T, Belard E, et al
    Fecal Calprotectin Measured By Patients at Home Using Smartphones-A New Clinical Tool in Monitoring Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  408. GISBERT JP, Barreiro-de Acosta M, Esteve M, Garcia-Sanchez V, et al
    Physician Perspectives on Unresolved Issues in the Management of Ulcerative Colitis: The UC Horizons Project.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  409. NEILSON K, Ftanou M, Monshat K, Salzberg M, et al
    A Controlled Study of a Group Mindfulness Intervention for Individuals Living With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  410. ZELMAN-TOISTER E, Bakos E, Cohen S, Zigmond E, et al
    CD151 Regulates T-Cell Migration in Health and Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  411. SARTINI A, Di Girolamo M, Bertani A, Villa E, et al
    "Blindly" ADA Dose Escalation to 80 mg Weekly in Crohn's Disease Patients with LOR: Is It Cost Effective or Not?
    Inflamm Bowel Dis. 2015;21:E27-8.
    PubMed     Text format    


    October 2015
  412. UHLIG HH, Schwerd T
    From Genes to Mechanisms: The Expanding Spectrum of Monogenic Disorders Associated with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  413. FIGUEIREDO VC, Markworth JF, Durainayagam BR, Pileggi CA, et al
    Impaired Ribosome Biogenesis and Skeletal Muscle Growth in a Murine Model of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  414. PUTIGNANI L, Del Chierico F, Vernocchi P, Cicala M, et al
    Gut Microbiota Dysbiosis as Risk and Premorbid Factors of IBD and IBS Along the Childhood-Adulthood Transition.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  415. BITTON A, Vutcovici M, Sewitch M, Suissa S, et al
    Mortality Trends in Crohn's Disease and Ulcerative Colitis: A Population-based Study in Quebec, Canada.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  416. SASAKI MM, Skol AD, Hungate EA, Bao R, et al
    Whole-exome Sequence Analysis Implicates Rare Il17REL Variants in Familial and Sporadic Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  417. DESILETS M, Deng X, Rao C, Ensminger AW, et al
    Genome-based Definition of an Inflammatory Bowel Disease-associated Adherent-Invasive Escherichia coli Pathovar.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


    September 2015
  418. GERBARG PL, Jacob VE, Stevens L, Bosworth BP, et al
    The Effect of Breathing, Movement, and Meditation on Psychological and Physical Symptoms and Inflammatory Biomarkers in Inflammatory Bowel Disease: A Randomized Controlled Trial.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  419. SHAH SL, Siegel CA
    Increasing Patient Activation Could Improve Outcomes for Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  420. HOLUBAR SD, Holder-Murray J, Flasar M, Lazarev M, et al
    Anti-Tumor Necrosis Factor-alpha Antibody Therapy Management Before and After Intestinal Surgery for Inflammatory Bowel Disease: A CCFA Position Paper.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  421. JANSE IC, Koldijk MJ, Spekhorst LM, Vila AV, et al
    Identification of Clinical and Genetic Parameters Associated with Hidradenitis Suppurativa in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  422. YE BD, Choi H, Hong M, Yun WJ, et al
    Identification of Ten Additional Susceptibility Loci for Ulcerative Colitis Through Immunochip Analysis in Koreans.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  423. MAKKAR R, Graff LA, Bharadwaj S, Lopez R, et al
    Psychological Factors in Irritable Pouch Syndrome and Other Pouch Disorders.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  424. LIMDI JK, Aggarwal D, McLaughlin JT
    Dietary Practices and Beliefs in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  425. MCCOMBIE A, Gearry R, Andrews J, Mulder R, et al
    Does Computerized Cognitive Behavioral Therapy Help People with Inflammatory Bowel Disease? A Randomized Controlled Trial.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  426. HERMAN ML, Kane SV
    Treatment Nonadherence in Inflammatory Bowel Disease: Identification, Scope, and Management Strategies.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  427. ROSEN DJ, Dubinsky MC
    The Evolving Role of Thiopurines for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format    


  428. KOUTROUBAKIS IE, Regueiro M, Schoen RE, Ramos-Rivers C, et al
    Multiyear Patterns of Serum Inflammatory Biomarkers and Risk of Colorectal Neoplasia in Patients with Ulcerative Colitis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  429. PENNINCK E, Fumery M, Armengol-Debeir L, Sarter H, et al
    Postoperative Complications in Pediatric Inflammatory Bowel Disease: A Population-based Study.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  430. HOVDE O, Smastuen MC, Hoivik ML, Bernklev T, et al
    Mortality and Causes of Death in Ulcerative Colitis: Results from 20 Years of Follow-up in the IBSEN Study.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  431. JOOSSE ME, Samsom JN, van der Woude CJ, Escher JC, et al
    The Role of Therapeutic Drug Monitoring of Anti-Tumor Necrosis Factor Alpha Agents in Children and Adolescents with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015;21:2214-21.
    PubMed     Text format     Abstract available


  432. GREGORI D
    Reply to Are Worries and Concerns Information Side Effects?
    Inflamm Bowel Dis. 2015;21:E23.
    PubMed     Text format    


  433. BERROA E, Fernandez-Salazar L, Rodriguez McCullough N, Garrote Adrados JA, et al
    Are Worries and Concerns Information Side Effects?
    Inflamm Bowel Dis. 2015;21:E22.
    PubMed     Text format    


    August 2015
  434. GIBSON DJ, Elliott L, McDermott E, Tosetto M, et al
    Heightened Expression of CD39 by Regulatory T Lymphocytes Is Associated with Therapeutic Remission in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  435. ANANTHAKRISHNAN AN, Cagan A, Cai T, Gainer VS, et al
    Identification of Nonresponse to Treatment Using Narrative Data in an Electronic Health Record Inflammatory Bowel Disease Cohort.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  436. LEE AJ, Kraemer DF, Smotherman C, Eid E, et al
    Providing Our Fellows in Training with Education on Inflammatory Bowel Disease Health Maintenance to Improve the Quality of Care in Our Health Care System.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  437. LEE KK, Jharap B, Maser EA, Colombel JF, et al
    Impact of Concomitant Endometriosis on Phenotype and Natural History of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  438. CRISTOBAL I, Manso R, Gonzalez-Alonso P, Madoz-Gurpide J, et al
    Clinical Value of miR-26b Discriminating Ulcerative Colitis-associated Colorectal Cancer in the Subgroup of Patients with Metastatic Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format    


  439. O'CONNOR A, Packey CD, Akbari M, Moss AC, et al
    Mesalamine, but Not Sulfasalazine, Reduces the Risk of Colorectal Neoplasia in Patients with Inflammatory Bowel Disease: An Agent-specific Systematic Review and Meta-analysis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  440. HASHASH JG, Chintamaneni P, Ramos Rivers CM, Koutroubakis IE, et al
    Patterns of Antibiotic Exposure and Clinical Disease Activity in Inflammatory Bowel Disease: A 4-year Prospective Study.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  441. TRIER MOLLER F, Andersen V, Andersson M, Jess T, et al
    Hospital Admissions, Biological Therapy, and Surgery in Familial and Sporadic Cases of Inflammatory Bowel Disease: A Population-Based Cohort Study 1977-2011.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  442. VALENTINO PL, Feldman BM, Walters TD, Griffiths AM, et al
    Abnormal Liver Biochemistry Is Common in Pediatric Inflammatory Bowel Disease: Prevalence and Associations.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  443. MCCURDY JD, Enders FT, Jones A, Killian JM, et al
    Detection of Cytomegalovirus in Patients with Inflammatory Bowel Disease: Where to Biopsy and How Many Biopsies?
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  444. SLEVIN SM, Egan LJ
    New Insights into the Mechanisms of Action of Anti-Tumor Necrosis Factor-alpha Monoclonal Antibodies in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  445. DEL PINTO R, Pietropaoli D, Chandar AK, Ferri C, et al
    Association Between Inflammatory Bowel Disease and Vitamin D Deficiency: A Systematic Review and Meta-analysis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  446. STALLHOFER J, Friedrich M, Konrad-Zerna A, Wetzke M, et al
    Lipocalin-2 Is a Disease Activity Marker in Inflammatory Bowel Disease Regulated by IL-17A, IL-22, and TNF-alpha and Modulated by IL23R Genotype Status.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  447. BOLLEN L, Vande Casteele N, Peeters M, Van Assche G, et al
    The Occurrence of Thrombosis in Inflammatory Bowel Disease Is Reflected in the Clot Lysis Profile.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  448. POLYTARCHOU C, Oikonomopoulos A, Mahurkar S, Touroutoglou A, et al
    Assessment of Circulating MicroRNAs for the Diagnosis and Disease Activity Evaluation in Patients with Ulcerative Colitis by Using the Nanostring Technology.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  449. BOYLE M, Ting A, Cury DB, Nanda K, et al
    Adherence to Rectal Mesalamine in Patients with Ulcerative Colitis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  450. VANHOVE W, Peeters PM, Staelens D, Schraenen A, et al
    Strong Upregulation of AIM2 and IFI16 Inflammasomes in the Mucosa of Patients with Active Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  451. LEAL MC, Dabritz J
    Immunoregulatory Role of Myeloid-derived Cells in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  452. YAMAMOTO-FURUSHO JK, Fonseca-Camarillo G
    Genetic Markers Associated with Clinical Outcomes in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  453. DITISHEIM S, Fournier N, Juillerat P, Pittet V, et al
    Inflammatory Articular Disease in Patients with Inflammatory Bowel Disease: Result of the Swiss IBD Cohort Study.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  454. ALLEGRETTI JR, Borges L, Lucci M, Chang M, et al
    Risk Factors for Rehospitalization Within 90 Days in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  455. MONAGHAN TM, Cockayne A, Mahida YR
    Pathogenesis of Clostridium difficile Infection and Its Potential Role in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015;21:1957-1966.
    PubMed     Text format     Abstract available


  456. SHEN J, Mao AP, Zhu MM, Zhao P, et al
    Ulcerative Colitis Database: An Integrated Database and Toolkit for Gene Function and Medication Involved in Ulcerative Colitis.
    Inflamm Bowel Dis. 2015;21:1872-1882.
    PubMed     Text format     Abstract available


  457. HUTH K, Benchimol EI, Aglipay M, Mack DR, et al
    Strategies to Improve Influenza Vaccination in Pediatric Inflammatory Bowel Disease Through Education and Access.
    Inflamm Bowel Dis. 2015;21:1761-1768.
    PubMed     Text format     Abstract available


  458. BOUSVAROS A
    Thalidomide Treatment of Pediatric Ulcerative Colitis: A New Use for an Old Drug.
    Inflamm Bowel Dis. 2015;21:1750-1751.
    PubMed     Text format    


  459. GASHIN L, Cheifetz AS
    Reply to Use of CT Scan in Ulcerative Colitis Patients Presenting to the Emergency Department.
    Inflamm Bowel Dis. 2015;21:E21.
    PubMed     Text format    


  460. SEMINERIO JL, Koutroubakis IE, Ramos-Rivers C, Hashash JG, et al
    Impact of Obesity on the Management and Clinical Course of Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  461. STIDHAM RW, Waljee AK, Day NM, Bergmans CL, et al
    Reply to Body Fat Composition Predicts Infectious Complications After Bowel Resection in Crohn's Disease.
    Inflamm Bowel Dis. 2015;21:E19-20.
    PubMed     Text format    


  462. LI Y, Zhu W
    Body Fat Composition Predicts Infectious Complications After Bowel Resection in Crohn's Disease.
    Inflamm Bowel Dis. 2015;21:E19.
    PubMed     Text format    


    July 2015
  463. ANANTHAKRISHNAN AN, Khalili H, Song M, Higuchi LM, et al
    High School Diet and Risk of Crohn's Disease and Ulcerative Colitis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  464. DAVE M, Mehta K, Luther J, Baruah A, et al
    Mesenchymal Stem Cell Therapy for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  465. FULLER-THOMSON E, West KJ, Sulman J, Baird SL, et al
    Childhood Maltreatment Is Associated with Ulcerative Colitis but Not Crohn's Disease: Findings from a Population-based Study.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  466. RISPO A, Testa A, De Palma GD, Donetto S, et al
    Different Profile of Efficacy of Thiopurines in Ulcerative Colitis and Crohn's Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  467. GREENLEY RN, Gumidyala AP, Nguyen E, Plevinsky JM, et al
    Can You Teach a Teen New Tricks? Problem Solving Skills Training Improves Oral Medication Adherence in Pediatric Patients with Inflammatory Bowel Disease Participating in a Randomized Trial.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  468. DOSHI-VELEZ F, Avillach P, Palmer N, Bousvaros A, et al
    Prevalence of Inflammatory Bowel Disease Among Patients with Autism Spectrum Disorders.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  469. FULLER-THOMSON E, Lateef R, Sulman J
    Robust Association Between Inflammatory Bowel Disease and Generalized Anxiety Disorder: Findings from a Nationally Representative Canadian Study.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  470. SHUKLA T, Singh S, Loftus EV Jr, Bruining DH, et al
    Antiviral Therapy in Steroid-refractory Ulcerative Colitis with Cytomegalovirus: Systematic Review and Meta-analysis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  471. GOREN I, Yahav L, Tulchinsky H, Dotan I, et al
    Serology of Patients with Ulcerative Colitis After Pouch Surgery Is More Comparable with that of Patients with Crohn's Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  472. KINNUCAN J, Tomal J, Rubin DT
    U.S. Patients with Ulcerative Colitis Do Not Have a Decreased Risk of Diverticulosis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  473. CHEN P, Bakke D, Kolodziej L, Lodolce J, et al
    Antrum Mucosal Protein-18 Peptide Targets Tight Junctions to Protect and Heal Barrier Structure and Function in Models of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  474. KINI AT, Thangaraj KR, Simon E, Shivappagowdar A, et al
    Aberrant Niche Signaling in the Etiopathogenesis of Ulcerative Colitis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  475. HENAO MP, Bewtra M, Osterman MT, Aberra FN, et al
    Measurement of Inflammatory Bowel Disease Symptoms: Reliability of an Abbreviated Approach to Data Collection.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  476. PEREIRA C, Gracio D, Teixeira JP, Magro F, et al
    Oxidative Stress and DNA Damage: Implications in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  477. WATERMAN M, Knight J, Dinani A, Xu W, et al
    Predictors of Outcome in Ulcerative Colitis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  478. JABEEN R, Miller L, Yao W, Gupta S, et al
    Altered STAT4 Isoform Expression in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  479. MANES G, Fontana P, de Nucci G, Radaelli F, et al
    Colon Cleansing for Colonoscopy in Patients with Ulcerative Colitis: Efficacy and Acceptability of a 2-L PEG Plus Bisacodyl Versus 4-L PEG.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  480. VESTER-ANDERSEN MK, Prosberg MV, Vind I, Andersson M, et al
    Low Risk of Unemployment, Sick Leave, and Work Disability Among Patients with Inflammatory Bowel Disease: A 7-year Follow-up Study of a Danish Inception Cohort.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  481. CHIA R, Borum ML
    African Americans May Access the Emergency Department for Inflammatory Bowel Disease Care More Often than Whites.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format    


  482. NABI S
    Use of CT Scan in Ulcerative Colitis Patients Presenting to the Emergency Department.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format    


  483. VAVRICKA SR, Schoepfer A, Scharl M, Lakatos PL, et al
    Extraintestinal Manifestations of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  484. MORENO-RINCON E, Benitez JM, Serrano-Ruiz FJ, Vazquez-Moron JM, et al
    Prognosis of Patients with Ulcerative Colitis in Sustained Remission After Thiopurines Withdrawal.
    Inflamm Bowel Dis. 2015;21:1564-71.
    PubMed     Text format     Abstract available



  485. Elevated IL-13Ra2 in Intestinal Epithelial Cells From Ulcerative Colitis or Colorectal Cancer Initiates MAPK Pathway: RETRACTION.
    Inflamm Bowel Dis. 2015;21:1736.
    PubMed     Text format    


  486. EHRENPREIS ED, Habib I, Mazulis A, Roginsky G, et al
    Reply to Morse and Sartor.
    Inflamm Bowel Dis. 2015;21:E12.
    PubMed     Text format    


  487. ZAND A, van Deen WK, Inserra EK, Hall L, et al
    Presenteeism in Inflammatory Bowel Diseases: A Hidden Problem with Significant Economic Impact.
    Inflamm Bowel Dis. 2015;21:1623-30.
    PubMed     Text format     Abstract available


  488. PARAMSOTHY S, Borody TJ, Lin E, Finlayson S, et al
    Donor Recruitment for Fecal Microbiota Transplantation.
    Inflamm Bowel Dis. 2015;21:1600-6.
    PubMed     Text format     Abstract available


  489. CERRILLO E, Beltran B, Pous S, Echarri A, et al
    Fecal Calprotectin in Ileal Crohn's Disease: Relationship with Magnetic Resonance Enterography and a Pathology Score.
    Inflamm Bowel Dis. 2015;21:1572-9.
    PubMed     Text format     Abstract available


  490. KOBOZIEV I, Jones-Hall Y, Valentine JF, Webb CR, et al
    Use of Humanized Mice to Study the Pathogenesis of Autoimmune and Inflammatory Diseases.
    Inflamm Bowel Dis. 2015;21:1652-73.
    PubMed     Text format     Abstract available


  491. WIESE DM, Beaulieu D, Slaughter JC, Horst S, et al
    Use of Endoscopic Ultrasound to Guide Adalimumab Treatment in Perianal Crohn's Disease Results in Faster Fistula Healing.
    Inflamm Bowel Dis. 2015;21:1594-9.
    PubMed     Text format     Abstract available


  492. GRAY WN, Resmini AR, Baker KD, Holbrook E, et al
    Concerns, Barriers, and Recommendations to Improve Transition from Pediatric to Adult IBD Care: Perspectives of Patients, Parents, and Health Professionals.
    Inflamm Bowel Dis. 2015;21:1641-51.
    PubMed     Text format     Abstract available


  493. SARO C, Ceballos D, Munoz F, De la Coba C, et al
    Resources Utilization and Costs the Year Before and After Starting Treatment with Adalimumab in Crohn's Disease Patients.
    Inflamm Bowel Dis. 2015;21:1631-40.
    PubMed     Text format     Abstract available


  494. HIEJIMA E, Kawai T, Nakase H, Tsuruyama T, et al
    Reduced Numbers and Proapoptotic Features of Mucosal-associated Invariant T Cells as a Characteristic Finding in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015;21:1529-40.
    PubMed     Text format     Abstract available


  495. PILLET S, Jarlot C, Courault M, Del Tedesco E, et al
    Infliximab Does Not Worsen Outcomes During Flare-ups Associated with Cytomegalovirus Infection in Patients with Ulcerative Colitis.
    Inflamm Bowel Dis. 2015;21:1580-6.
    PubMed     Text format     Abstract available


  496. YARUR AJ, Rubin DT
    Therapeutic Drug Monitoring of Anti-tumor Necrosis Factor Agents in Patients with Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2015;21:1709-18.
    PubMed     Text format     Abstract available


  497. CHANDAR AK, Singh S, Murad MH, Peyrin-Biroulet L, et al
    Efficacy and Safety of Natalizumab and Vedolizumab for the Management of Crohn's Disease: A Systematic Review and Meta-analysis.
    Inflamm Bowel Dis. 2015;21:1695-708.
    PubMed     Text format     Abstract available


  498. FLANAGAN PK, Chiewchengchol D, Wright HL, Edwards SW, et al
    Killing of Escherichia coli by Crohn's Disease Monocyte-derived Macrophages and Its Enhancement by Hydroxychloroquine and Vitamin D.
    Inflamm Bowel Dis. 2015;21:1499-510.
    PubMed     Text format     Abstract available


    June 2015
  499. PEDERSEN N, Munkholm P
    Methodological Approach to Mesalazine Treatment in Patients with Mild-to-moderate Ulcerative Colitis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format    


  500. KHALILI H, Chan AT
    Reply to Comments on Measures of Obesity and Risk of Crohn's Disease and Ulcerative Colitis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format    


  501. AHN HS
    Increased Incidence of Inflammatory Bowel Disease in Korea May Not Be Explained by Food Additives.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format    


  502. MENDALL M, Chan D, Kumar D
    Comments on Measures of Obesity and Risk of Crohn's Disease and Ulcerative Colitis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format    


  503. FONSECA-CAMARILLO G, Yamamoto-Furusho JK
    Immunoregulatory Pathways Involved in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  504. QIN X
    How to Explain the Dramatic Increase Around 2000 but Recent Leveling Off of Inflammatory Bowel Disease in Korea?
    Inflamm Bowel Dis. 2015.
    PubMed     Text format    


  505. MURTHY SK, Greenberg GR, Croitoru K, Nguyen GC, et al
    Extent of Early Clinical Response to Infliximab Predicts Long-term Treatment Success in Active Ulcerative Colitis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  506. MCCOMBIE AM, Mulder RT, Gearry RB
    Coping Strategies and Psychological Outcomes of Patients with Inflammatory Bowel Disease in the First 6 Months After Diagnosis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  507. GOTTLIEB K, Travis S, Feagan B, Hussain F, et al
    Central Reading of Endoscopy Endpoints in Inflammatory Bowel Disease Trials.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  508. BENDERSKA N, Dittrich AL, Knaup S, Rau TT, et al
    miRNA-26b Overexpression in Ulcerative Colitis-associated Carcinogenesis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  509. CHEHOUD C, Albenberg LG, Judge C, Hoffmann C, et al
    Fungal Signature in the Gut Microbiota of Pediatric Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  510. AGILLI M, Dogan T, Ergin G
    Methodological Approach to Mesalazine Treatment in Patients with Mild-to-moderate Ulcerative Colitis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format    


  511. HOLDER-MURRAY J, Marsicovetere P, Holubar SD
    Minimally invasive surgery for inflammatory bowel disease.
    Inflamm Bowel Dis. 2015;21:1443-58.
    PubMed     Text format     Abstract available


  512. BOYNTON K, Flynn A, Box T, Dalpiaz A, et al
    Inflammatory bowel disease education: I can hear the extension for community healthcare outcomes.
    Inflamm Bowel Dis. 2015;21:1407-8.
    PubMed     Text format    


  513. KIM SY, Park SH
    Reply to What is the Role of Diffusion-weighted Imaging in Ileocolonic Crohn's Disease?
    Inflamm Bowel Dis. 2015;21:E9-E10.
    PubMed     Text format    


  514. BUISSON A, Hordonneau C, Goutte M, Bommelaer G, et al
    What is the Role of Diffusion-weighted Imaging in Ileocolonic Crohn's Disease?
    Inflamm Bowel Dis. 2015;21:E9.
    PubMed     Text format    


  515. SUSKIND DL
    Reply to can fecal microbial transplant effectively treat Crohn's disease?
    Inflamm Bowel Dis. 2015;21:E8.
    PubMed     Text format    


  516. DAI C, Jiang M, Sun MJ
    Can fecal microbial transplant effectively treat Crohn's disease?
    Inflamm Bowel Dis. 2015;21:E8.
    PubMed     Text format    


  517. HUANG VW, Prosser C, Kroeker KI, Wang H, et al
    Knowledge of Fecal Calprotectin and Infliximab Trough Levels Alters Clinical Decision-making for IBD Outpatients on Maintenance Infliximab Therapy.
    Inflamm Bowel Dis. 2015;21:1359-67.
    PubMed     Text format     Abstract available


  518. BERNSTEIN CN, Garland A, Peschken CA, Hitchon CA, et al
    Predictors of ICU Admission and Outcomes 1 Year Post-Admission in Persons with IBD: A Population-based Study.
    Inflamm Bowel Dis. 2015;21:1341-7.
    PubMed     Text format     Abstract available


  519. PANACCIONE R, Sandborn WJ, Gordon GL, Lee SD, et al
    Briakinumab for treatment of Crohn's disease: results of a randomized trial.
    Inflamm Bowel Dis. 2015;21:1329-40.
    PubMed     Text format     Abstract available


  520. BRAMHALL M, Florez-Vargas O, Stevens R, Brass A, et al
    Quality of methods reporting in animal models of colitis.
    Inflamm Bowel Dis. 2015;21:1248-59.
    PubMed     Text format     Abstract available


  521. LE PN, Greer JB, Oikonomou I, Schraut WH, et al
    IBD LIVE Case Series-Case 2: Previous Cancer in a Patient with Crohn's Disease: Is It Appropriate to Use Biologics and Immunosuppressants for IBD Treatment?
    Inflamm Bowel Dis. 2015;21:1401-6.
    PubMed     Text format    


  522. WANG W, Jovel J, Halloran B, Wine E, et al
    Metagenomic analysis of microbiome in colon tissue from subjects with inflammatory bowel diseases reveals interplay of viruses and bacteria.
    Inflamm Bowel Dis. 2015;21:1419-27.
    PubMed     Text format     Abstract available


  523. LISSNER D, Schumann M, Batra A, Kredel LI, et al
    Monocyte and M1 Macrophage-induced Barrier Defect Contributes to Chronic Intestinal Inflammation in IBD.
    Inflamm Bowel Dis. 2015;21:1297-305.
    PubMed     Text format     Abstract available


  524. DE VALLIERE C, Wang Y, Eloranta JJ, Vidal S, et al
    G Protein-coupled pH-sensing Receptor OGR1 Is a Regulator of Intestinal Inflammation.
    Inflamm Bowel Dis. 2015;21:1269-81.
    PubMed     Text format     Abstract available


  525. ZUBIN G, Peter L
    Predicting Endoscopic Crohn's Disease Activity Before and After Induction Therapy in Children: A Comprehensive Assessment of PCDAI, CRP, and Fecal Calprotectin.
    Inflamm Bowel Dis. 2015;21:1386-91.
    PubMed     Text format     Abstract available


  526. WRIGHT EK, Kamm MA, Teo SM, Inouye M, et al
    Recent advances in characterizing the gastrointestinal microbiome in Crohn's disease: a systematic review.
    Inflamm Bowel Dis. 2015;21:1219-28.
    PubMed     Text format     Abstract available


  527. STIDHAM RW, Waljee AK, Day NM, Bergmans CL, et al
    Body fat composition assessment using analytic morphomics predicts infectious complications after bowel resection in Crohn's disease.
    Inflamm Bowel Dis. 2015;21:1306-13.
    PubMed     Text format     Abstract available


  528. SZIGETHY E, Youk AO, Gonzalez-Heydrich J, Bujoreanu SI, et al
    Effect of 2 psychotherapies on depression and disease activity in pediatric Crohn's disease.
    Inflamm Bowel Dis. 2015;21:1321-8.
    PubMed     Text format     Abstract available


  529. CHANG MI, Cohen BL, Greenstein AJ
    A review of the impact of biologics on surgical complications in Crohn's disease.
    Inflamm Bowel Dis. 2015;21:1472-7.
    PubMed     Text format     Abstract available


  530. SINH P, Shen B
    Endoscopic evaluation of surgically altered bowel in patients with inflammatory bowel diseases.
    Inflamm Bowel Dis. 2015;21:1459-71.
    PubMed     Text format     Abstract available


    May 2015
  531. FEUERSTEIN JD, Jiang ZG, Belkin E, Lewandowski JJ, et al
    Surgery for Ulcerative Colitis Is Associated with a High Rate of Readmissions at 30 Days.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  532. COHEN RD, Dalal SR
    Systematic Review: Rectal Therapies for the Treatment of Distal Forms of Ulcerative Colitis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  533. VAVRICKA SR, Rogler G, Gantenbein C, Spoerri M, et al
    Chronological Order of Appearance of Extraintestinal Manifestations Relative to the Time of IBD Diagnosis in the Swiss Inflammatory Bowel Disease Cohort.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  534. LAZZERINI M, Martelossi S, Ventura A
    Thalidomide Treatment of Pediatric Ulcerative Colitis: A New Use for an Old Drug.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format    


  535. BENNIKE TB, Carlsen TG, Ellingsen T, Bonderup OK, et al
    Neutrophil Extracellular Traps in Ulcerative Colitis: A Proteome Analysis of Intestinal Biopsies.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  536. GONDIM FA, de Oliveira GR, Teles BC, Aquino PS, et al
    Clinical and Electrodiagnostic Findings in Patients with Peripheral Neuropathy and Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  537. BOOTZ F, Schmid AS, Neri D
    Alternatively Spliced EDA Domain of Fibronectin Is a Target for Pharmacodelivery Applications in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  538. MERKLEY SA, Beaulieu DB, Horst S, Duley C, et al
    Use of Intravenous Immunoglobulin for Patients with Inflammatory Bowel Disease with Contraindications or Who Are Unresponsive to Conventional Treatments.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  539. CHERFANE CE, Gessel L, Cirillo D, Zimmerman MB, et al
    Monocytosis and a Low Lymphocyte to Monocyte Ratio Are Effective Biomarkers of Ulcerative Colitis Disease Activity.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  540. VIENNOIS E, Zhao Y, Merlin D
    Biomarkers of Inflammatory Bowel Disease: From Classical Laboratory Tools to Personalized Medicine.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  541. LEE HS, Yang SK, Soh JS, Lee S, et al
    Short- and Long-Term Outcomes of Acute Severe Ulcerative Colitis in Korea: The 1999-2005 Cohort.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  542. KOUTSOCHRISTOU V, Zellos A, Dimakou K, Panayotou I, et al
    Dental Caries and Periodontal Disease in Children and Adolescents with Inflammatory Bowel Disease: A Case-Control Study.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  543. DEZFOLI S, Horton HA, Thepyasuwan N, Berel D, et al
    Combined Immunosuppression Impairs Immunogenicity to Tetanus and Pertussis Vaccination Among Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  544. MELESSE DY, Targownik LE, Singh H, Blanchard JF, et al
    Patterns and Predictors of Long-term Nonuse of Medical Therapy Among Persons with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  545. LONG MD, Gulati A, Wohl D, Herfarth H, et al
    Immunizations in Pediatric and Adult Patients with Inflammatory Bowel Disease: A Practical Case-based Approach.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  546. ALRUBAIY L, Rikaby I, Sageer M, Hutchings HA, et al
    Systematic Review of the Clinical Disease Severity Indices for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  547. DAI C, Jiang M, Sun MJ
    Can fecal calprotection identify postoperative recurrence of Crohn's disease?
    Inflamm Bowel Dis. 2015;21:E7.
    PubMed     Text format    


  548. QIU Y
    Reply to can fecal calprotection identify postoperative recurrence of Crohn's disease?
    Inflamm Bowel Dis. 2015;21:E7.
    PubMed     Text format    


  549. WRIGHT EK, Kamm MA
    Impact of drug therapy and surgery on quality of life in Crohn's disease: a systematic review.
    Inflamm Bowel Dis. 2015;21:1187-94.
    PubMed     Text format     Abstract available


  550. LEE MN, Kang B, Choi SY, Kim MJ, et al
    Relationship between azathioprine dosage, 6-thioguanine nucleotide levels, and therapeutic response in pediatric patients with IBD treated with azathioprine.
    Inflamm Bowel Dis. 2015;21:1054-62.
    PubMed     Text format     Abstract available


  551. WHITEOAK SR, Felwick R, Sanchez-Elsner T, Fraser Cummings JR, et al
    MicroRNAs in inflammatory bowel diseases: paradoxes and possibilities.
    Inflamm Bowel Dis. 2015;21:1160-5.
    PubMed     Text format     Abstract available


  552. BOUGUEN G, Laharie D, Nancey S, Hebuterne X, et al
    Efficacy and safety of adalimumab 80 mg weekly in luminal Crohn's disease.
    Inflamm Bowel Dis. 2015;21:1047-53.
    PubMed     Text format     Abstract available


  553. DOTSON JL, Bashaw H, Nwomeh B, Crandall WV, et al
    Management of intra-abdominal abscesses in children with Crohn's disease: a 12-year, retrospective single-center review.
    Inflamm Bowel Dis. 2015;21:1109-14.
    PubMed     Text format     Abstract available


  554. HUANG EY, Inoue T, Leone VA, Dalal S, et al
    Using corticosteroids to reshape the gut microbiome: implications for inflammatory bowel diseases.
    Inflamm Bowel Dis. 2015;21:963-72.
    PubMed     Text format     Abstract available


  555. LEWIS A, Nijhuis A, Mehta S, Kumagai T, et al
    Intestinal fibrosis in Crohn's disease: role of microRNAs as fibrogenic modulators, serum biomarkers, and therapeutic targets.
    Inflamm Bowel Dis. 2015;21:1141-50.
    PubMed     Text format     Abstract available


  556. PAPA A, Papa V, Marzo M, Scaldaferri F, et al
    Prevention and treatment of venous thromboembolism in patients with IBD: a trail still climbing.
    Inflamm Bowel Dis. 2015;21:1204-13.
    PubMed     Text format     Abstract available


    April 2015
  557. LAZZERINI M, Martelossi S, Magazzu G, Pellegrino S, et al
    Effect of Thalidomide on Clinical Remission in Children and Adolescents with Ulcerative Colitis Refractory to Other Immunosuppressives: Pilot Randomized Clinical Trial.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  558. SOH JS, Yun WJ, Kim KJ, Won CH, et al
    Concomitant use of azathioprine/6-mercaptopurine decreases the risk of anti-TNF-induced skin lesions.
    Inflamm Bowel Dis. 2015;21:832-9.
    PubMed     Text format     Abstract available


  559. HOLMES EA, Xiang F, Lucas RM
    Variation in incidence of pediatric Crohn's disease in relation to latitude and ambient ultraviolet radiation: a systematic review and analysis.
    Inflamm Bowel Dis. 2015;21:809-17.
    PubMed     Text format     Abstract available


  560. SCHWARTZ DA, Ghazi LJ, Regueiro M
    Guidelines for medical treatment of Crohn's perianal fistulas: critical evaluation of therapeutic trials.
    Inflamm Bowel Dis. 2015;21:737-52.
    PubMed     Text format    


  561. ONG EM, Ghazi LJ, Schwartz DA, Mortele KJ, et al
    Guidelines for imaging of Crohn's perianal fistulizing disease.
    Inflamm Bowel Dis. 2015;21:731-6.
    PubMed     Text format    


  562. SCHWARTZ DA, Ghazi LJ, Regueiro M, Fichera A, et al
    Guidelines for the multidisciplinary management of Crohn's perianal fistulas: summary statement.
    Inflamm Bowel Dis. 2015;21:723-30.
    PubMed     Text format    


  563. DOTSON JL, Kappelman MD, Chisolm DJ, Crandall WV, et al
    Racial disparities in readmission, complications, and procedures in children with Crohn's disease.
    Inflamm Bowel Dis. 2015;21:801-8.
    PubMed     Text format     Abstract available


  564. FICHERA A, Zoccali M
    Guidelines for the surgical treatment of Crohn's perianal fistulas.
    Inflamm Bowel Dis. 2015;21:753-8.
    PubMed     Text format    


  565. GRIGORAS CA, Ziakas PD, Jayamani E, Mylonakis E, et al
    ATG16L1 and IL23R variants and genetic susceptibility to crohn's disease: mode of inheritance based on meta-analysis of genetic association studies.
    Inflamm Bowel Dis. 2015;21:768-76.
    PubMed     Text format     Abstract available


  566. FALVEY JD, Hoskin T, Meijer B, Ashcroft A, et al
    Disease activity assessment in IBD: clinical indices and biomarkers fail to predict endoscopic remission.
    Inflamm Bowel Dis. 2015;21:824-31.
    PubMed     Text format     Abstract available


  567. KEVANS D, Turpin W, Madsen K, Meddings J, et al
    Determinants of intestinal permeability in healthy first-degree relatives of individuals with Crohn's disease.
    Inflamm Bowel Dis. 2015;21:879-87.
    PubMed     Text format     Abstract available


  568. SHARMA S, Eckert D, Hyams JS, Mensing S, et al
    Pharmacokinetics and exposure-efficacy relationship of adalimumab in pediatric patients with moderate to severe Crohn's disease: results from a randomized, multicenter, phase-3 study.
    Inflamm Bowel Dis. 2015;21:783-92.
    PubMed     Text format     Abstract available


  569. LIU S, Zhang Y, Ren J, Li J, et al
    Microbial DNA recognition by cGAS-STING and other sensors in dendritic cells in inflammatory bowel diseases.
    Inflamm Bowel Dis. 2015;21:901-11.
    PubMed     Text format     Abstract available


    March 2015
  570. MATALON S, Elad H, Brazowski E, Santo E, et al
    Serum alpha-1 antitrypsin: a noninvasive marker of pouchitis.
    Inflamm Bowel Dis. 2015;21:589-95.
    PubMed     Text format     Abstract available


  571. KURAHARA LH, Sumiyoshi M, Aoyagi K, Hiraishi K, et al
    Intestinal myofibroblast TRPC6 channel may contribute to stenotic fibrosis in Crohn's disease.
    Inflamm Bowel Dis. 2015;21:496-506.
    PubMed     Text format     Abstract available


  572. SUSKIND DL, Brittnacher MJ, Wahbeh G, Shaffer ML, et al
    Fecal microbial transplant effect on clinical outcomes and fecal microbiome in active Crohn's disease.
    Inflamm Bowel Dis. 2015;21:556-63.
    PubMed     Text format     Abstract available


  573. BOUGUEN G, Sninsky C, Tang KL, Colombel JF, et al
    Change in erythrocyte mean corpuscular volume during combination therapy with azathioprine and infliximab is associated with mucosal healing: a post hoc analysis from SONIC.
    Inflamm Bowel Dis. 2015;21:606-14.
    PubMed     Text format     Abstract available


  574. BIANCONE L, Onali S, Petruzziello C, Calabrese E, et al
    Cancer and immunomodulators in inflammatory bowel diseases.
    Inflamm Bowel Dis. 2015;21:674-98.
    PubMed     Text format     Abstract available


  575. WASILEWSKI A, Storr M, Zielinska M, Fichna J, et al
    Role of G protein-coupled orphan receptors in intestinal inflammation: novel targets in inflammatory bowel diseases.
    Inflamm Bowel Dis. 2015;21:666-73.
    PubMed     Text format     Abstract available


  576. KANI HT, Shen B
    Male issues of the ileal pouch.
    Inflamm Bowel Dis. 2015;21:716-22.
    PubMed     Text format     Abstract available


    February 2015
  577. BOSCHETTI G, Garnero P, Moussata D, Cuerq C, et al
    Accuracies of serum and fecal S100 proteins (calprotectin and calgranulin C) to predict the response to TNF antagonists in patients with Crohn's disease.
    Inflamm Bowel Dis. 2015;21:331-6.
    PubMed     Text format     Abstract available


  578. ASSA A, Vong L, Pinnell LJ, Rautava J, et al
    Vitamin D deficiency predisposes to adherent-invasive Escherichia coli-induced barrier dysfunction and experimental colonic injury.
    Inflamm Bowel Dis. 2015;21:297-306.
    PubMed     Text format     Abstract available


  579. KHARE V, Dammann K, Asboth M, Krnjic A, et al
    Overexpression of PAK1 promotes cell survival in inflammatory bowel diseases and colitis-associated cancer.
    Inflamm Bowel Dis. 2015;21:287-96.
    PubMed     Text format     Abstract available


  580. SINGH T, Levine AP, Smith PJ, Smith AM, et al
    Characterization of expression quantitative trait loci in the human colon.
    Inflamm Bowel Dis. 2015;21:251-6.
    PubMed     Text format     Abstract available


  581. CHHAYA V, Saxena S, Cecil E, Subramanian V, et al
    Impact of timing and duration of thiopurine treatment on first perianal surgery in Crohn's disease: UK population-based study (1995-2009).
    Inflamm Bowel Dis. 2015;21:385-91.
    PubMed     Text format     Abstract available


  582. QIU Y, Mao R, Chen BL, He Y, et al
    Fecal calprotectin for evaluating postoperative recurrence of Crohn's disease: a meta-analysis of prospective studies.
    Inflamm Bowel Dis. 2015;21:315-22.
    PubMed     Text format     Abstract available


  583. ZITOMERSKY NL, Atkinson BJ, Fournier K, Mitchell PD, et al
    Antibodies to infliximab are associated with lower infliximab levels and increased likelihood of surgery in pediatric IBD.
    Inflamm Bowel Dis. 2015;21:307-14.
    PubMed     Text format     Abstract available


  584. SIVIGNON A, de Vallee A, Barnich N, Denizot J, et al
    Saccharomyces cerevisiae CNCM I-3856 prevents colitis induced by AIEC bacteria in the transgenic mouse model mimicking Crohn's disease.
    Inflamm Bowel Dis. 2015;21:276-86.
    PubMed     Text format     Abstract available


  585. FRANCESCONE R, Hou V, Grivennikov SI
    Cytokines, IBD, and colitis-associated cancer.
    Inflamm Bowel Dis. 2015;21:409-18.
    PubMed     Text format     Abstract available


  586. BOLAND BS, Boyle DL, Sandborn WJ, Firestein GS, et al
    Validation of gene expression biomarker analysis for biopsy-based clinical trials in Crohn's disease.
    Inflamm Bowel Dis. 2015;21:323-30.
    PubMed     Text format     Abstract available


  587. ZIELINSKA M, Jarmuz A, Wasilewski A, Salaga M, et al
    Role of transient receptor potential channels in intestinal inflammation and visceral pain: novel targets in inflammatory bowel diseases.
    Inflamm Bowel Dis. 2015;21:419-27.
    PubMed     Text format     Abstract available


  588. BRESSENOT A, Peyrin-Biroulet L
    Histologic features predicting postoperative Crohn's disease recurrence.
    Inflamm Bowel Dis. 2015;21:468-75.
    PubMed     Text format     Abstract available


  589. ROGLER G, Vavricka S
    Exposome in IBD: recent insights in environmental factors that influence the onset and course of IBD.
    Inflamm Bowel Dis. 2015;21:400-8.
    PubMed     Text format     Abstract available


  590. KALMAN RS, Hartshorn K, Farraye FA
    Does a personal or family history of malignancy preclude the use of immunomodulators and biologics in IBD.
    Inflamm Bowel Dis. 2015;21:428-35.
    PubMed     Text format     Abstract available


  591. AMIN J, Huang B, Yoon J, Shih DQ, et al
    Update 2014: advances to optimize 6-mercaptopurine and azathioprine to reduce toxicity and improve efficacy in the management of IBD.
    Inflamm Bowel Dis. 2015;21:445-52.
    PubMed     Text format     Abstract available


    January 2015
  592. PEYRIN-BIROULET L
    Clinical remission as defined by the Mayo Score: do we deceive ourselves?
    Inflamm Bowel Dis. 2015;21:E2-3.
    PubMed     Text format    


  593. SAMAAN MA, Feagan BG, Sandborn WJ, Levesque BG, et al
    Clinical remission as defined by the Mayo Score: do we deceive ourselves?
    Inflamm Bowel Dis. 2015;21:E3-4.
    PubMed     Text format    


  594. THAPA SD
    IBD and extent of coronary atherosclerosis.
    Inflamm Bowel Dis. 2015;21:E1.
    PubMed     Text format    


  595. OPIPARI A, Franchi L
    Role of inflammasomes in intestinal inflammation and Crohn's disease.
    Inflamm Bowel Dis. 2015;21:173-81.
    PubMed     Text format     Abstract available


  596. KOPYLOV U, Nemeth A, Koulaouzidis A, Makins R, et al
    Small bowel capsule endoscopy in the management of established Crohn's disease: clinical impact, safety, and correlation with inflammatory biomarkers.
    Inflamm Bowel Dis. 2015;21:93-100.
    PubMed     Text format     Abstract available


  597. SELVAGGI F, Pellino G, Canonico S, Sciaudone G, et al
    Effect of preoperative biologic drugs on complications and function after restorative proctocolectomy with primary ileal pouch formation: systematic review and meta-analysis.
    Inflamm Bowel Dis. 2015;21:79-92.
    PubMed     Text format     Abstract available


  598. LOBATON T, Hoffman I, Vermeire S, Ferrante M, et al
    Aeromonas species: an opportunistic enteropathogen in patients with inflammatory bowel diseases? A single center cohort study.
    Inflamm Bowel Dis. 2015;21:71-8.
    PubMed     Text format     Abstract available


  599. JUILLERAT P, Sokol H, Froehlich F, Yajnik V, et al
    Factors associated with durable response to infliximab in Crohn's disease 5 years and beyond: a multicenter international cohort.
    Inflamm Bowel Dis. 2015;21:60-70.
    PubMed     Text format     Abstract available


  600. LONG MD, Cadigan RJ, Cook SF, Haldeman K, et al
    Perceptions of patients with inflammatory bowel diseases on biobanking.
    Inflamm Bowel Dis. 2015;21:132-8.
    PubMed     Text format     Abstract available


  601. YANG SK, Hong M, Choi H, Zhao W, et al
    Immunochip analysis identification of 6 additional susceptibility loci for Crohn's disease in Koreans.
    Inflamm Bowel Dis. 2015;21:1-7.
    PubMed     Text format     Abstract available


  602. SERWAS NK, Kansu A, Santos-Valente E, Kuloglu Z, et al
    Atypical manifestation of LRBA deficiency with predominant IBD-like phenotype.
    Inflamm Bowel Dis. 2015;21:40-7.
    PubMed     Text format     Abstract available


  603. SERIL DN, Yao Q, Lashner BA, Shen B, et al
    Autoimmune features are associated with chronic antibiotic-refractory pouchitis.
    Inflamm Bowel Dis. 2015;21:110-20.
    PubMed     Text format     Abstract available


  604. KIM KJ, Lee Y, Park SH, Kang BK, et al
    Diffusion-weighted MR enterography for evaluating Crohn's disease: how does it add diagnostically to conventional MR enterography?
    Inflamm Bowel Dis. 2015;21:101-9.
    PubMed     Text format     Abstract available


  605. PAPAMICHAEL K, Gils A, Rutgeerts P, Levesque BG, et al
    Role for therapeutic drug monitoring during induction therapy with TNF antagonists in IBD: evolution in the definition and management of primary nonresponse.
    Inflamm Bowel Dis. 2015;21:182-97.
    PubMed     Text format     Abstract available


  606. STODDARD PB, Ghazi LJ, Wong-You-Cheong J, Cross RK, et al
    Magnetic resonance enterography: state of the art.
    Inflamm Bowel Dis. 2015;21:229-39.
    PubMed     Text format     Abstract available


  607. LAN A, Blachier F, Benamouzig R, Beaumont M, et al
    Mucosal healing in inflammatory bowel diseases: is there a place for nutritional supplementation?
    Inflamm Bowel Dis. 2015;21:198-207.
    PubMed     Text format     Abstract available


    December 2014
  608. WILDT S, Rumessen JJ, Nordgaard-Lassen I
    Incorrect citation and analysis in meta-analysis.
    Inflamm Bowel Dis. 2014;20:E25.
    PubMed     Text format    


    September 2014
  609. GUSEVA D, Holst K, Kaune B, Meier M, et al
    Serotonin 5-HT7 receptor is critically involved in acute and chronic inflammation of the gastrointestinal tract.
    Inflamm Bowel Dis. 2014;20:1516-29.
    PubMed     Text format     Abstract available


  610. ASCOLANI M, Mescoli C, Palmieri G, Sica G, et al
    Colonic phenotype of the ileum in Crohn's disease: a prospective study before and after ileocolonic resection.
    Inflamm Bowel Dis. 2014;20:1555-61.
    PubMed     Text format     Abstract available


  611. MANSER CN, Frei P, Grandinetti T, Biedermann L, et al
    Risk factors for repetitive ileocolic resection in patients with Crohn's disease: results of an observational cohort study.
    Inflamm Bowel Dis. 2014;20:1548-54.
    PubMed     Text format     Abstract available


  612. SVRCEK M, Piton G, Cosnes J, Beaugerie L, et al
    Small bowel adenocarcinomas complicating Crohn's disease are associated with dysplasia: a pathological and molecular study.
    Inflamm Bowel Dis. 2014;20:1584-92.
    PubMed     Text format     Abstract available


  613. CARUSO A, D'Inca R, Scarpa M, Manfrin P, et al
    Diffusion-weighted magnetic resonance for assessing ileal Crohn's disease activity.
    Inflamm Bowel Dis. 2014;20:1575-83.
    PubMed     Text format     Abstract available


  614. PLEVINSKY JM, Greenley RN
    Exploring health-related quality of life and social functioning in adolescents with inflammatory bowel diseases after attending camp oasis and participating in a Facebook group.
    Inflamm Bowel Dis. 2014;20:1611-7.
    PubMed     Text format     Abstract available


  615. SHERMAN J, Greenstein AJ, Greenstein AJ
    Ileal j pouch complications and surgical solutions: a review.
    Inflamm Bowel Dis. 2014;20:1678-85.
    PubMed     Text format     Abstract available


  616. LI Y, Zhu W, Gong J, Zuo L, et al
    Influence of exclusive enteral nutrition therapy on visceral fat in patients with Crohn's disease.
    Inflamm Bowel Dis. 2014;20:1568-74.
    PubMed     Text format     Abstract available


  617. WRIGHT EK, De Cruz P, Gearry R, Day AS, et al
    Fecal biomarkers in the diagnosis and monitoring of Crohn's disease.
    Inflamm Bowel Dis. 2014;20:1668-77.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: